Additional Information
Book Details
Abstract
Use the proven format of the best-selling Secrets SeriesTM to prepare for the USMLE Step 1. Presented as questions and answers based on clinical vignettes, USMLE Step 1 Secrets will aid you in not only retaining but understanding key information for the boards. Co-authored by Dr.Tom Brown, author of Rapid Review in Physiology, and Dr.Dave Brown, the second edition has been updated to be even more concise and ultra high-yield, while still offering a complete overview of the key topics and the top “secrets” and personal insights from the authors.
- Utilizes a case-based approach to prepare you for the Step 1 exam.
- Implements systems-based organization for an integrated approach.
- Uses the Secrets Q&A format to make learning interesting and effective.
- Uses a new Top 100 Secrets chapter as a recap of the most important information in the book to help you review quickly.
- Incorporates 7 new chapters, including Clinical Anatomy and Pharmacology, and Toxicology to expand coverage of high-yield areas and keep you current.
- Provides maximum information in minimal time to help fit a concise review into your busy schedule.
- Includes a color pathology and dermatology section to enhance the clarity and understanding of key images.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Usmle Step 1 Secrets | iii | ||
Copyright | iv | ||
Contributors | v | ||
Preface | vii | ||
More Secrets for Success on the Usmle Step 1 | xi | ||
Contents | xv | ||
Chapter 1: Cardiology | 1 | ||
Basic concepts-hemodynamics | 1 | ||
1. What are the mathematical determinants of the arterial blood pressure? | 1 | ||
2. What are the primary determinants of cardiac output? | 1 | ||
3. What are the three main factors that affect stroke volume? | 2 | ||
4. What is preload, and how does it affect stroke volume? | 2 | ||
5. What is contractility and how does it affect stroke volume? | 2 | ||
6. What is afterload and how does it affect stroke volume? | 3 | ||
7. What are the primary determinants of peripheral resistance? | 3 | ||
8. What is the mechanism by which the sympathetic nervous system responds to a reduction in blood pressure? | 3 | ||
9. How do the α1-receptor antagonists work? | 4 | ||
10. How do the α1-receptor antagonists cause orthostatic hypotension? | 4 | ||
11. What hemodynamic changes occur during exercise? | 4 | ||
12. Which clinical scenarios would shift the CO and venous return curves to the points labeled 1 to 4 on Figure1-3? | 4 | ||
Basic concepts-excitation-contraction coupling | 5 | ||
1. What is the source of cytosolic calcium during ventricular systole? | 5 | ||
2. What is the function of calcium in cardiac muscle contraction? | 6 | ||
3. What is the mechanism by which β-adrenergic stimulation increases cardiac contractility? | 6 | ||
4. What is the contribution of the sympathetic nervous system to ventricular relaxation? | 6 | ||
Basic concepts-arrhythmias | 6 | ||
1. What is the relationship between the various phases of the ventricular myocyte action potential and the different ion flux | 6 | ||
2. What is responsible for the drifting of the resting membrane potential in nodal cells? | 7 | ||
3. Through what mechanism does sympathetic stimulation increase heart rate? | 7 | ||
4. What are the classes of antiarrhythmics and how do their mechanisms of action and potential side effects vary? | 8 | ||
Case 1-1 | 9 | ||
1. What are the types of hypertension and which does this patient most likely have? | 9 | ||
2. How is hypertension defined and what are the potential complications? | 9 | ||
3. What are four classes of drugs that could be useful in treating this man's hypertension? | 10 | ||
4. What is the mechanism by which metoprolol will reduce blood pressure in this man? | 10 | ||
5. What pharmacologic property makes certain beta blockers more ``cardioselective´´ than others? | 10 | ||
6. Caution should be used in prescribing beta blockers for patients with which comorbid conditions and why? | 10 | ||
7. What might be occurring in this patient and how would you recommend he discontinue his medication? | 11 | ||
Case 1-2 | 12 | ||
1. How would the fact that this patient also has diabetes influence treatment for his hypertension? Consider drug choice and | 12 | ||
2. What are the mechanisms by which ACE inhibitors lower blood pressure? | 12 | ||
3. Why might the use of beta blockers to control this man's hypertension not be an ideal choice | 13 | ||
4. What effect might starting a thiazide diuretic have on glycemic control in this patient? | 13 | ||
Case 1-2 continued: | 13 | ||
5. What is the mechanism by which ACE inhibitors, such as lisinopril, can cause a cough? | 13 | ||
6. Cover the columns on the right side of Table1-3, and for each antihypertensive drug in the left column, try to name the | 13 | ||
Case1-3 | 15 | ||
1. What is the likely diagnosis? | 15 | ||
2. Does this patient have stable or unstable angina? How are they different, and which is more serious? | 16 | ||
3. How can angina occur in the absence of coronary atherosclerosis? | 16 | ||
4. What are the principal physiologic determinants of myocardial oxygen supply? | 16 | ||
5. What are the principal physiologic determinants of myocardial oxygen demand? | 17 | ||
6. Which factors contribute to a myocardial oxygen demand that exceeds supply in this man? | 17 | ||
7. Why is nitroglycerin effective in eliminating anginal pain? | 17 | ||
8. What are the mechanisms by which beta blockers decrease myocardial oxygen demand and, therefore, the symptoms of angina? | 17 | ||
Case 1-3 continued: | 18 | ||
9. How could a similar evaluation be made in a patient in whom an exercise stress is contraindicated (e.g., orthopedic condit | 18 | ||
Case1-4 | 18 | ||
1. What disorder is on top of the differential diagnosis list at this point and why? | 18 | ||
2. What are some common risk factors for myocardial infarction and cardiovascular disease in general? | 18 | ||
3. What kind of myocardial infarction is this patient experiencing? | 19 | ||
4. In addition to analysis of the electrocardiogram, what serum tests could be ordered to confirm | 19 | ||
5. What other treatment option is available besides angioplasty to restore coronary blood flow? | 19 | ||
6. What is the physiologic rationale for giving beta blockers to patients who have had heart attacks? | 20 | ||
7. How might a myocardial infarction result in the following short- and long-term abnormalities? | 20 | ||
8. What is sudden cardiac death, and why are patients who have had myocardial infarctions predisposed to it? | 21 | ||
Case1-5 | 22 | ||
1. What disorder is at the top of your differential diagnosis list? | 22 | ||
Case 1-5 continued: | 22 | ||
2. In pathophysiologic terms, what is heart failure? | 22 | ||
3. What are the differences between systolic and diastolic heart failure? Which does this woman most likely have? | 22 | ||
4. What is the etiology of heart failure? | 23 | ||
5. The body's response to heart failure is initially helpful but becomes maladaptive with time. | 23 | ||
6. Given the pathophysiologic adaptations in heart failure just noted, why might beta blockers be beneficial in heart failure? | 24 | ||
7. How is digitalis, which is used in heart failure, believed to increase cardiac contractility? | 24 | ||
8. In Table1-4, cover the right-hand column and attempt to give the mechanism of action for each of the listed drugs used. . . | 25 | ||
Other Related Questions | 25 | ||
9. What is ``high-output´´ heart failure? | 25 | ||
Case1-6 | 26 | ||
1. What is the diagnosis? | 26 | ||
2. What likely predisposed this patient to developing aortic stenosis? | 26 | ||
3. What causes heart murmurs and why does this patient have one? | 26 | ||
4. What compensatory left ventricular changes occur as a result of aortic stenosis? | 27 | ||
5. Why does this patient have a weak, delayed carotid upstroke with a narrowed pulse pressure on physical | 27 | ||
6. As a result of aortic stenosis, do ventricular myocytes spend more time in isotonic or isometric (isovolumic) contraction? | 28 | ||
7. Explain the cause of this patient's presenting complaints. What is most likely causing his episodes of syncope? His chest... | 28 | ||
8. What are some causes of increased myocardial oxygen demand in aortic stenosis? | 28 | ||
9. What are some causes of decreased myocardial oxygen supply in aortic stenosis? | 28 | ||
10. Why is atrial fibrillation a particularly dangerous complication in aortic stenosis (aside from the risk of embolic strok)? | 28 | ||
11. Describe the murmur of aortic stenosis | 29 | ||
Case1-7 | 30 | ||
1. This patient's constellation of symptoms is consistent with what syndrome, and what is its significance? | 30 | ||
2. Part of this woman's presentation is dyslipidemia, a disorder of lipoprotein metabolism. | 30 | ||
3. What are the functions of the various forms of lipoproteins? How are they removed from the circulation? | 31 | ||
Case 1-7 continued:: | 31 | ||
4. What is the mechanism of action of simvastatin (and other statins)? | 31 | ||
5. In addition to liver tests, which other enzymes might be monitored when using a statin? | 31 | ||
6. What are the cause and clinical significance of this woman's hypertriglyceridemia? | 31 | ||
7. What enzymatic mechanism clears triglycerides from the circulation? | 32 | ||
8. What is the clinical significance of elevations in LDL levels? | 32 | ||
9. What is the clinical significance of this patient's low HDL-C? | 32 | ||
10. What is the mechanism of action of the lipid-lowering fibrates/fibric acid derivatives (e.g., gemfibrozil, fenofibrate)? | 32 | ||
11. How does niacin influence the lipid profile, and what is the unique pharmacologic feature of niacin | 32 | ||
12. How do the bile-sequestering resins (e.g., cholestyramine, colestipol) lower LDL cholesterol levels? | 33 | ||
Other Related Question | 33 | ||
13. What is the cause of the disorder of lipid metabolism known as abetalipoproteinemia? | 33 | ||
Chapter 2: Pulmonology | 34 | ||
Basic concepts-mechanics of breathing | 34 | ||
1. What are the driving forces for the following: | 34 | ||
2. What are the forces of resistance for the following: | 34 | ||
3. What does pulmonary compliance measure? | 36 | ||
4. With respect to the compliance curve of the lungs, how might breathing at an elevated functional residual capacity in chro | 36 | ||
5. What does pulmonary elastance measure? How is pulmonary elastance altered in restrictive and obstructive lung diseases and | 36 | ||
6. How does surfactant affect alveolar surface tension? | 37 | ||
7. Why are smaller alveoli more prone to collapse, and how is this relevant to neonatal respiratory distress syndrome? | 37 | ||
8. What is the minute ventilation? | 37 | ||
9. What is ``dead space´´? What is the difference between anatomic dead space and physiologic dead space? | 38 | ||
10. Why is the alveolar minute ventilation a much better representation of functional ventilation? | 38 | ||
Basic concepts-ventilation-perfusion matching | 38 | ||
11. What does the ventilation/perfusion ratio measure, and what is its approximate value? What is an ``ideal´´ value for | 38 | ||
12. What conditions cause an increase in the / ratio? | 39 | ||
13. What causes a decrease in the ventilation/perfusion ratio? | 39 | ||
14. What effect does chronic obstructive pulmonary disease usually have on the ventilation-perfusion ratio? | 39 | ||
15. What is the difference between an anatomic shunt and a physiologic shunt? | 39 | ||
Basic concepts-gas exchange | 39 | ||
16. What influences the diffusion of gases from the alveoli into the pulmonary capillaries, and vice versa? | 39 | ||
17. What is the alveolar-arterial oxygen gradient and what is the clinical significance of its magnitude? | 40 | ||
18. How is the alveolar-arterial oxygen gradient calculated? | 40 | ||
19. What are the primary determinants of respiratory drive? | 40 | ||
20. How does increasing or decreasing the arterial Pco2 affect pH? | 41 | ||
21. What is respiratory acidosis? Respiratory alkalosis? | 41 | ||
22. What are the forced expiratory volume and the FEV1/FVC ratio? | 41 | ||
23. What is the principal difference between ``restrictive´´ and ``obstructive´´ lung disease with respect to | 41 | ||
Case2-1 | 42 | ||
1. What disorder do you suspect? | 42 | ||
Case2-1 continued: | 42 | ||
2. What is the diagnosis? How is this condition classified? | 43 | ||
3. What is the pathophysiologic process causing symptoms in this woman? | 43 | ||
4. About 5% of asthmatics are sensitive to aspirin, and some may even develop fatal bronchospasm from ingesting aspirin. W... | 43 | ||
5. What is exercise-induced asthma? | 43 | ||
6. What is the explanation for the decreased FEV1/FVC ratio in this woman? | 43 | ||
7. Why does methacholine cause her FEV1/FVC ratio to decrease? | 43 | ||
8. What is the residual lung volume and how is it affected in an asthma attack? | 44 | ||
9. Why is wheezing generally heard most during expiration in asthma? | 44 | ||
10. With respect to the pathophysiology of asthma, what are the two mechanistic targets of pharmacologic intervention? | 44 | ||
11. Quick review: Cover the two columns on the right side of Table2-2 and identify the class of drug and mechanism of | 44 | ||
12. Why are albuterol and salmeterol preferable to isoproterenol in treating asthma? | 44 | ||
13. This patient was put on a combination inhaler that contained a β2-agonist and a corticosteroid. A month or so later she n | 45 | ||
14. Why are cromolyn sodium and nedocromil useful in the prevention but not treatment of asthmatic attacks? | 45 | ||
15. What histologic changes would be expected in the bronchial smooth muscle and mucosa if a biopsy were performed in this pa | 45 | ||
16. What is theophylline and what are some of the drawbacks of its use? | 45 | ||
Case2-2 | 46 | ||
1. What are some potential causes of this man's symptoms? | 46 | ||
Case2-2 continued: | 46 | ||
2. What is the most likely diagnosis at this time? | 46 | ||
3. What is the pathophysiology of this disorder and why doesn't albuterol help? | 46 | ||
4. How is hypersensitivity pneumonitis treated? | 46 | ||
Case2-3 | 47 | ||
1. What is the suspected diagnosis? | 47 | ||
2. What other tests can be done to more confidently establish this diagnosis? | 47 | ||
3. What is causing the pulmonary infiltrate? | 47 | ||
Case2-4 | 47 | ||
1. What is the most likely diagnosis in this patient? | 48 | ||
2. How would your differential diagnosis change if the patient presented with a 2-week history | 48 | ||
3. What are some common causes of pneumonia in different age groups? | 48 | ||
Case2-5 | 48 | ||
1. What is the differential diagnosis? | 48 | ||
Case2-5 continued: | 48 | ||
2. What is the diagnosis? | 49 | ||
3. What is the pathophysiologic explanation for the decreased FEV1/FVC ratio in this woman? | 49 | ||
4. What was the most likely cause of emphysema in this woman? | 49 | ||
5. What histopathologic changes would a biopsy of this woman's lung likely reveal? | 49 | ||
6. How do centriacinar and panacinar emphysema differ in terms of morphology and etiology? | 50 | ||
7. Why may administration of large volumes of concentrated O2 to this woman cause hypoventilation? | 50 | ||
8. How does emphysema cause the right ventricular hypertrophy seen on this patient's electrocardiogram? | 50 | ||
Related Questions on Chronic Obstructive Pulmonary Disease | 50 | ||
9. Why is an individual with α1-antitrypsin deficiency at increased risk for developing emphysema? | 50 | ||
10. Why do patients with emphysema breathe through pursed lips? | 50 | ||
11. What pharmacologic agents are used to treat chronic obstructive pulmonary disease? | 51 | ||
Case2-6 | 52 | ||
1. What is the likely diagnosis? | 52 | ||
2. Why may cigarette smoking predispose to chronic lung infections? | 52 | ||
Case2-6 continued: | 52 | ||
3. What is the pathogenesis of chronic bronchitis? | 52 | ||
4. What is the basis of the reduced FEV1/FVC ratio in chronic bronchitis? | 52 | ||
5. What is an acute exacerbation of chronic obstructive pulmonary disease? What classes of medications should be avoided or p | 52 | ||
6. What acid-base abnormality is commonly found in chronic obstructive pulmonary disease patients and what is its origin? | 53 | ||
7. How might mechanical ventilation lead to respiratory alkalosis? | 53 | ||
Case2-7 | 54 | ||
1. What is the likely diagnosis? | 54 | ||
Case2-7 continued: | 54 | ||
2. What is the diagnosis? | 54 | ||
3. What are asbestos, asbestosis, and the pneumoconioses? | 54 | ||
4. To which malignancies does asbestosis predispose? | 55 | ||
5. What are some other common causes of pulmonary fibrosis? | 55 | ||
6. What is the pathophysiologic explanation for the reduction in forced vital capacity in this man? | 56 | ||
7. What lung biopsy finding may be present in this patient that is unique to asbestosis? | 56 | ||
Case2-8 | 56 | ||
1. What is the likely cause of this woman's dyspnea? | 56 | ||
2. What is the difference between the Pao2 and the arterial oxygen content? | 56 | ||
Case2-8 continued: | 57 | ||
3. What does arterial oxygen saturation measure? | 57 | ||
4. Why doesn't this woman's anemia make her cyanotic? | 57 | ||
5. How is the anemia contributing to this woman's dyspnea? | 57 | ||
Related Questions | 58 | ||
6. What are typical values for arterial and venous Po2 and what do they represent with respect to the hemoglobin dissociation | 58 | ||
7. Would exposure to carbon monoxide be expected to affect the Pao2? Explain. | 58 | ||
8. Differentiate between external and internal respiration. Which is affected by anemia? | 59 | ||
Case2-9 | 60 | ||
1. What is the anticipated diagnosis? | 60 | ||
2. What are the etiology and pathogenesis of this disease? | 60 | ||
3. How is this condition managed? | 60 | ||
4. What is the diffusion equation and which parameter is influenced most by the high concentration of inspired oxygen? | 60 | ||
5. Both congestive heart failure and acute respiratory distress syndrome can cause significant pulmonary edema. How does the | 60 | ||
6. Why is it necessary to be particularly cautious in giving fluids to this patient? | 60 | ||
Related Question | 61 | ||
7. Using the diffusion equation, explain why each of the conditions in Table2-6 is associated with hypoxemia: | 61 | ||
Case2-10 | 61 | ||
1. What type of lung cancer does this woman likely have? | 61 | ||
2. If a patient with small cell carcinoma develops bilateral ptosis (droopy eyelids) as well as neuromuscular weakness, what | 62 | ||
3. If a lung tumor is growing at the apex of the lung and compressing the cervical sympathetic chain on that side, what manif | 62 | ||
4. Although there are several different histologic types of lung cancer, what are the two principal classifications and why d | 63 | ||
5. Why are radon levels routinely measured before homes are purchased? | 63 | ||
6. How can squamous cell carcinoma cause hypercalcemia without any bony metastases? | 63 | ||
Differential Diagnosis | 63 | ||
7. If a patient with small cell carcinoma has hypertension, hypernatremia, hypokalemia, abdominal striae, and a ``buffalo hu | 63 | ||
Case2-11 | 63 | ||
1. What must be included in the differential diagnosis? | 63 | ||
Case2-11 continued: | 64 | ||
2. Now what is the most likely diagnosis? | 64 | ||
3. Why was the lymph node biopsy performed? | 64 | ||
4. How can sarcoidosis cause cor pulmonale (right ventricular failure)? | 64 | ||
5. How is pulmonary hypertension defined? | 64 | ||
6. What is the difference between primary and secondary pulmonary hypertension? | 64 | ||
7. How can sarcoidosis cause a restrictive cardiomyopathy? | 64 | ||
Case2-12 | 65 | ||
1. What is the diagnosis? | 65 | ||
2. Why should the chest tube be inserted immediately superior to the lower rib in the intercostal space in which it is insert | 65 | ||
3. What is the pressure inside the pleural cavity (intrapleural space) normally? | 65 | ||
4. How does hypoxia-induced vasoconstriction help compensate, to some extent, for the respiratory dysfunction caused by pneum | 65 | ||
5. Is this patient more likely to be experiencing respiratory acidosis or respiratory alkalosis? Explain. | 66 | ||
6. What effect will a pneumothorax have on the serum ionized calcium level? | 66 | ||
Chapter 3: Nephrology | 67 | ||
Clinical renal disease | 67 | ||
Case3-1 | 67 | ||
1. What is the probable cause of this patient's problems? | 67 | ||
2. What are the three etiologic classifications of acute renal failure? | 68 | ||
3. How is glomerular filtration rate (GFR) calculated? | 68 | ||
4. Why is the absence of hematuria on urinalysis important in establishing the diagnosis? | 68 | ||
5. Why was it important to ask this patient about tricyclic antidepressants, antipsychotics, antihistamines, and sympathomime | 69 | ||
Case3-2 | 69 | ||
1. What is the probable diagnosis? | 69 | ||
2. What is the pathophysiology of acute tubular necrosis? | 69 | ||
3. What is the cause of the decreased glomerular filtration rate and oliguria seen in acute tubular necrosis? | 70 | ||
4. What are the three phases of acute tubular necrosis? | 70 | ||
5. Other than the presence of ``muddy brown´´ casts, how can prerenal azotemia due to ischemia be differentiated from i | 70 | ||
Related Question | 71 | ||
6. What is rhabdomyolysis and how can it cause acute tubular necrosis? | 71 | ||
Case3-3 | 71 | ||
1. What is the most likely cause for her acute renal failure? | 72 | ||
2. What are the three major types of NSAID-induced renal toxicity? | 72 | ||
Case3-4 | 73 | ||
1. What is most likely causing her blood urea nitrogen and creatinine elevation? | 73 | ||
2. What is the value of the normal fasting glucose and hemoglobin A1c levels in the differential diagnosis? | 73 | ||
3. What is the difficulty in establishing that this patient's renal failure was definitely due to hypertension | 74 | ||
4. How does this woman's renal failure explain her hypocalcemia? | 74 | ||
5. Would parathyroid hormone levels be increased or decreased in this patient? | 74 | ||
6. How does parathyroid hormone normally act to regulate serum Ca2+? How are parathyroid hormone levels normally regulated? | 74 | ||
7. What are the potential pathologic manifestations of the hyperparathyroidism that develops in renal failure? | 75 | ||
8. Why is this patient also predisposed to osteomalacia? | 76 | ||
9. How could this woman's renal failure explain the following findings? | 76 | ||
10. Is this woman suffering from azotemia or uremia? | 76 | ||
11. If she were uremic, and a friction rub was detected on physical examination, what might you suspect? | 76 | ||
Case3-5 | 77 | ||
1. What is the diagnosis? | 77 | ||
2. What is the primary complication of this disease? | 77 | ||
3. Why must urinary tract infections be treated aggressively in patients with this disease? | 77 | ||
4. If this patient suddenly develops a severe headache, what vascular abnormality must be suspected? | 77 | ||
5. How does autosomal dominant polycystic kidney disease differ from autosomal recessive polycystic kidney | 78 | ||
6. What is tuberous sclerosis and how can it be differentiated from ADPKD? | 78 | ||
7. What is von Hippel-Lindau syndrome and how can it be differentiated from ADPKD? | 79 | ||
8. What is medullary cystic disease and how can it be differentiated from ADPKD? | 79 | ||
9. Quick review: Cover the far right column in Table3-1 and give the characteristic features of each of the cystic... | 79 | ||
10. Why is medullary sponge kidney not included in Table 3-1? | 79 | ||
11. What is the most common cause of renal cysts? | 79 | ||
Case3-6 | 81 | ||
1. What is the likely diagnosis in this child and why? | 81 | ||
2. What is the likely cause of nephrotic syndrome in this patient? | 81 | ||
3. Assuming minimal change disease as the underlying pathologic condition, what would you expect gross histologic examinatio... | 81 | ||
4. Why might this boy be susceptible to infections while suffering from this illness? | 82 | ||
5. How should this boy be managed? Should a renal biopsy be performed? | 82 | ||
6. What are other major causes of nephrotic syndrome? | 82 | ||
Some Differential Diagnosis Concepts | 86 | ||
7. What condition might you suspect in a 6-year-old girl who presents with abdominal pain, joint pain, hematuria (or melena) | 86 | ||
Case3-7 | 86 | ||
1. What is the likely diagnosis? | 87 | ||
2. What segment of the nephron is involved in acute nephritis? How does this compare with the nephrotic syndrome? | 87 | ||
3. What was the likely cause of this man's sore throat and what is its relationship to the renal dysfunction? | 87 | ||
4. If the patient had recently suffered from cellulitis rather than pharyngitis, would it alter the diagnosis of his renal di | 88 | ||
5. What is the treatment for poststreptococcal glomerulonephritis? | 88 | ||
6. How would the diagnosis change if a renal biopsy revealed ``glomerular crescents´´? | 88 | ||
7. What is the most common cause of nephritis worldwide? | 89 | ||
8. What syndrome do you suspect in a 13-year-old boy with microscopic hematuria and hearing loss? | 90 | ||
Differential Diagnosis | 90 | ||
9. Quick review: Cover the right column in Table3-3 and attempt to diagnose the cause of the glomerulonephritis base... | 90 | ||
Case3-8 | 91 | ||
1. What is the diagnosis? | 91 | ||
2. What are the most common causes of nephrolithiasis? | 91 | ||
3. How can nephrolithiasis cause renal failure? | 91 | ||
4. What are the most common causes of hypercalcemia among both outpatients and inpatients? | 92 | ||
5. Why is hypercalcemia secondary to hyperparathyroidism less likely to cause renal calculi formation than other causes of hy | 93 | ||
Related Questions | 93 | ||
6. How does urinary tract infection with bacteria such as Proteus mirabilis predispose to struvite stone formation? | 93 | ||
7. How does urinary pH influence the precipitation of uric acid stones? | 93 | ||
8. What is cystinuria and how does it lead to cystine stones? | 93 | ||
9. How does Crohn's disease lead to an increased risk of kidney stones? | 93 | ||
Case3-9 | 94 | ||
1. What is the most likely diagnosis? | 95 | ||
2. What is the most common source of infection in pyelonephritis? | 95 | ||
3. Why are pregnant women with asymptomatic bacteriuria treated more aggressively than nonpregnant women with the same... | 95 | ||
4. Why are pregnant women with bacteriuria more susceptible to pyelonephritis? | 95 | ||
5. What is acute interstitial nephritis and how does it differ from acute pyelonephritis? | 95 | ||
6. Why are urinary tract infections in men younger than 50 often evaluated aggressively? | 95 | ||
7. Why are men older than 50 predisposed to urinary tract infection? | 96 | ||
Chapter 4: Fluid and Electrolytes | 97 | ||
Basic concepts-renal filtration and transport processes | 97 | ||
1. What forces govern the glomerular filtration rate at the level of the glomerulus? | 97 | ||
2. How do angiotensin-converting enzyme inhibitors and angiotensin receptor blockers affect glomerular filtration rate? | 98 | ||
3. What is meant by the term filtration fraction and how will increasing the glomerular capillary oncotic pressure (without... | 98 | ||
4. What are the three layers of the glomerular ``filter´´ and how do they contribute to the process of renal filtratio... | 99 | ||
5. What is the significance of the creatinine clearance and how is it measured? | 99 | ||
Basic concepts-renal control of acid-base balance | 101 | ||
1. Why is net renal acid excretion necessary to maintain acid-base homeostasis? | 101 | ||
2. What mechanisms does the kidney use to maintain acid-base balance despite this acid load? | 101 | ||
3. How do the kidneys reabsorb filtered bicarbonate? | 102 | ||
4. What effect does the diuretic acetazolamide have on the acid-base balance of the body? In what clinical conditions migh... | 102 | ||
5. How are bicarbonate and ammonium generated de novo by the kidney? | 103 | ||
Basic concepts-renal control of extracellular fluid balance | 104 | ||
1. What are the extracellular fluid compartments of the body and how do their relative sizes compare to the intracellular... | 104 | ||
2. How do the kidneys regulate extracellular fluid volume? | 104 | ||
3. What is the normal role of the renin-angiotensin-aldosterone system? | 104 | ||
4. What is the role of the sympathetic nervous system in maintaining effective circulating volume? | 104 | ||
5. How does the antidiuretic hormone regulate extracellular fluid volume? | 105 | ||
Case4-1 | 105 | ||
1. What disease did this patient have and what is its underlying cause? | 105 | ||
2. How does the renin-angiotensin-aldosterone system contribute to renovascular hypertension? | 105 | ||
3. How do the kidneys regulate blood pressure independently of the renin-angiotensin-aldosterone system? | 105 | ||
4. If angiotensin II promotes vasoconstriction, why doesn't the angiotensin II released during hypovolemic states reduce glom | 106 | ||
5. Why should angiotensin-converting enzyme inhibitors (or angiotensin receptor blockers) be avoided | 106 | ||
Renal Control of Extracellular Fluid Osmolarity | 107 | ||
Case4-2 | 107 | ||
1. What is the most likely diagnosis and what is its cause? | 107 | ||
Case4-2 continued: | 107 | ||
2. What syndromes are associated with syndrome of inappropriate secretion of antidiuretic hormone ? | 107 | ||
3. What is the function of antidiuretic hormone? | 108 | ||
4. Why is the antidiuretic hormone release in SIADH ``inappropriate´´? | 108 | ||
5. What is the result of inadequate antidiuretic hormone release? | 108 | ||
6. How does hyponatremia result in the central nervous system symptoms (fatigue, anorexia, and confusion) seen in this patie... | 109 | ||
7. Why must the hyponatremia be corrected slowly in this patient? | 109 | ||
8. Why was it important to ask about vomiting, diarrhea, or diuretic use? | 109 | ||
9. Why was it important to examine the albumin level and look for evidence of heart failure? | 109 | ||
10. How would levels of plasma antidiuretic hormone, plasma osmolarity, and serum osmolarity be expected to differ between... | 110 | ||
Pharmacology of Diuretics | 110 | ||
1. How do diuretics work to lower extracellular fluid volume? | 110 | ||
2. What percentage of the filtered sodium is reabsorbed under normal conditions (i.e., in the absence of diuretics)? | 110 | ||
3. In which region of the nephron does each of the major diuretic types (carbonic anhydrase inhibitors, osmotic diuretics... | 112 | ||
4. How does each major diuretic type affect the concentrations of serum electrolytes? | 113 | ||
5. What are the other relatively common or important side effects of diuretics? | 115 | ||
Chapter 5: Acid-Base Balance | 117 | ||
Basic concepts | 117 | ||
1. How is extracellular hydrogen ion concentration regulated? | 117 | ||
2. How does a change in HCO3 or in Pco2 affect pH? | 117 | ||
Case5-1 | 117 | ||
1. What is the primary acid-base disorder? | 118 | ||
2. What are the mechanisms involved in metabolic acidosis due to diarrhea? | 118 | ||
3. What else is considered in the differential diagnosis for non-anion gap metabolic acidosis? | 119 | ||
4. Is there appropriate compensation or is there a mixed disorder in this patient? | 119 | ||
5. What would it mean if, in the same patient, appropriate compensation was not present and Pco2 was instead 30mm Hg? | 119 | ||
Case5-2 | 121 | ||
1. What is the primary acid-base disorder? | 121 | ||
2. What is the differential diagnosis in this patient? | 121 | ||
3. Is there appropriate compensation or is this a mixed disorder? | 122 | ||
4. Does the degree of compensation allow you to draw any conclusions as to the duration of the condition? | 123 | ||
Case5-3 | 124 | ||
1. What is the primary acid-base disorder? | 124 | ||
2. What is the differential diagnosis in this patient? | 124 | ||
3. What is the pathophysiology of each of the conditions in the differential diagnosis? | 124 | ||
4. Is there appropriate compensation or is there a mixed disorder? | 125 | ||
Case5-3 continued: | 125 | ||
5. What is the most likely diagnosis? | 125 | ||
6. Would administration of saline be helpful in this patient? | 125 | ||
Case5-4 | 126 | ||
1. What is the primary acid-base disorder? | 126 | ||
2. Is there appropriate compensation or is this a mixed disorder? | 126 | ||
3. What is the next step in diagnosis of this disorder? | 126 | ||
4. How can there be such a large anion gap with such an extremely low pH when the disturbance in HCO3- is so minimal? | 127 | ||
Case5-4 continued: | 127 | ||
5. What is the most likely diagnosis in this patient? | 127 | ||
6. What is on the differential diagnosis for large anion gap metabolic acidosis? | 129 | ||
7. What is the correct treatment? | 129 | ||
Case5-5 | 129 | ||
1. What is the most likely diagnosis? | 129 | ||
Case5-5 continued: | 130 | ||
2. Now what is the most likely diagnosis? | 130 | ||
3. What is the treatment for the man in questions 1 and 2? | 130 | ||
Case5-6 | 130 | ||
1. What is the most likely diagnosis? | 131 | ||
Case5-7 | 131 | ||
1. What is the primary acid-base disorder? | 132 | ||
2. What is the differential diagnosis in this patient? | 132 | ||
3. What is the most likely diagnosis in this patient? | 132 | ||
4. Is there appropriate compensation or is this a mixed disorder? | 132 | ||
Case5-7 continued: | 132 | ||
5. How can you determine if this exacerbation is due to central hypoventilation from sedation or due to a ventilation-perf... | 132 | ||
Chapter 6: Gastroenterology | 134 | ||
Basic concepts | 134 | ||
1. What is the major stimulus for gastrin secretion? What are the physiologic actions of gastrin in the stomach? | 134 | ||
2. What are the main pancreatic enzymes and what are their functions? | 134 | ||
3. What are the primary hormonal stimuli for the pancreatic exocrine secretions and how do these secretions | 135 | ||
4. What are the primary stimuli for the secretion of cholecystokinin and secretin and from where are these hormones secreted? | 135 | ||
5. What other digestive processes does cholecystokinin stimulate? | 135 | ||
6. What is the function of the bile salts? How are they formed? | 135 | ||
7. What is the enterohepatic circulation and why is it important in the digestion of fats? | 135 | ||
8. What defines the foregut, midgut, and hindgut anatomically? Which main arteries provide the blood supply to each segment? | 135 | ||
9. What are the anatomic layers of the gut wall? | 136 | ||
Case6-1 | 136 | ||
1. What is the differential diagnosis? | 136 | ||
Case6-1 continued: | 137 | ||
2. Based on the findings in Figure6-2, what is the patient's likely diagnosis? | 138 | ||
3. Discuss the pathophysiology of gastroesophageal reflux disease. | 138 | ||
Case6-1 continued: | 138 | ||
4. Cover the far left column of Table6-1 and attempt to name the drugs used in the treatment of GERD based on the class of ... | 138 | ||
5. Which of the drugs in Table6-1 are contraindicated in a patient in whom bowel obstruction is suspected and why? | 139 | ||
6. Why may the omeprazole this patient was given cause him to develop hypergastrinemia? | 139 | ||
Case6-1 continued: | 139 | ||
7. Which complications of gastroesophageal reflux disease could be responsible for the patient's difficulty swallowing? | 139 | ||
8. Differentiate between the two types of esophageal cancers-adenocarcinoma and squamous cell carcinoma-in terms of... | 139 | ||
9. Why would a patient with Sjögren's syndrome be more susceptible to esophageal pathology in gastroesophageal reflux diseas... | 139 | ||
Case6-2 | 140 | ||
1. In pathophysiologic terms, how do you approach dysphagia? | 140 | ||
Case6-2 continued: | 140 | ||
2. What is the likely diagnosis in this woman? Describe the pathophysiology of this disease. | 141 | ||
3. Chagas´ disease is also known to be a cause of achalasia. What is the pathologic mechanism and what organism is the... | 141 | ||
4. What was the likely cause of this woman's previous episode of pneumonia? | 141 | ||
5. In addition to pneumatic dilatation of the lower esophageal sphincter and surgical myotomy, injection of botulinum toxin... | 141 | ||
Case6-3 | 143 | ||
1. What is the differential diagnosis? | 143 | ||
Case6-3 continued: | 143 | ||
2. If you were this man's physician, what would you have done differently in the treatment of this patient? | 143 | ||
3. How are nonsteroidal anti-inflammatory drugs thought to predispose to the formation of gastric ulcers? What alternatives... | 144 | ||
Case6-3 continued: | 144 | ||
4. Based on the appearance of the stool, is this more likely a lower gastrointestinal bleed or an upper gastrointestinal... | 144 | ||
5. What are the major complications of peptic ulcer disease? | 144 | ||
Chapter 7: Hepatology | 164 | ||
Basic concepts | 164 | ||
1. Review the anatomy of the hepatic lobule and portal triad. In what manner do blood and bile flow through a lobule? | 164 | ||
2. What is the chemical difference between conjugated and unconjugated bilirubin and how are these substances formed? | 164 | ||
3. Why is unconjugated bilirubin not normally excreted in the urine? | 165 | ||
4. What are the main causes of jaundice and how does each affect the type of hyperbilirubinemia observed? | 165 | ||
5. Which veins feed into the portal vein? | 167 | ||
6. What are the symptoms of portal hypertension? | 167 | ||
7. How can Budd-Chiari syndrome arise and what can it lead to? | 168 | ||
8. What are the common liver biochemical tests and what do they indicate? | 168 | ||
Case7-1 | 169 | ||
1. What is the most common cause of upper gastrointestinal bleeding? | 169 | ||
2. Why should a Mallory-Weiss tear be included in the differential diagnosis? | 169 | ||
3. What is scleral icterus? | 169 | ||
4. To confirm your suspicion about severe liver disease in this patient, what physical examination | 169 | ||
Case7-1 continued: | 169 | ||
5. What is the pathophysiology of his ascites, pedal edema, and periorbital edema? | 169 | ||
6. What is the pathogenesis of the suspected cause of hematemesis in this patient? | 170 | ||
Case7-1 continued: | 171 | ||
7. What is the value of the following tests: hepatitis serology, serum iron, ceruloplasmin, and antimitochondrial antibodies? | 171 | ||
8. Assuming he is not taking any anticoagulants, what is the most likely reason this patient developed a large hematoma... | 171 | ||
9. List all the laboratory findings you would expect in a patient with liver failure. | 171 | ||
10. Would you expect the ascitic fluid to be a transudate or an exudate? | 172 | ||
11. How does liver cirrhosis cause the following abnormalities? | 172 | ||
12. How can an acute alcohol binge cause a fatty liver to develop? | 173 | ||
13. How does chronic alcohol consumption lead to a more rapid catabolism of ingested alcohol? | 173 | ||
14. Why are ethanol and fomepizole used to treat methanol poisoning and ethylene glycol poisoning? | 174 | ||
Case7-2 | 174 | ||
1. To what disease is the student referring? | 175 | ||
2. What laboratory tests and further physical examination components would you like to do to strengthen your suspicion for... | 175 | ||
Case7-2 continued: | 175 | ||
3. How is the diagnosis of Wilson's disease made definitively? | 175 | ||
4. What is the pathogenesis of Wilson's disease? | 175 | ||
5. If this patient remains untreated, what neurologic manifestations may develop? | 175 | ||
6. What is the treatment for Wilson's disease and how does it work? | 175 | ||
Case7-3 | 176 | ||
1. In terms of infections, what do you include in the differential diagnosis for a patient who has recently traveled out of... | 176 | ||
Case7-3 continued: | 176 | ||
2. What is the diagnosis? | 176 | ||
3. Why is there an elevation of both direct and indirect bilirubin? | 176 | ||
4. Explain how the results of the hepatitis profile facilitate the diagnosis of an acute infection rather than a chronic one. | 177 | ||
5. Should he be concerned about developing a chronic infection or hepatic cirrhosis? | 177 | ||
6. How would you expect liver ``function´´ test patterns to differ between parenchymal liver disease and cholestatic... | 177 | ||
7. Now let's review some characteristic features of the different hepatitis viruses. | 177 | ||
8. Can hepatitis A be prevented? | 177 | ||
Case7-4 | 179 | ||
1. What is the most likely diagnosis? | 179 | ||
2. Why does physiologic jaundice develop? | 179 | ||
3. Why did the physician check for hematomas on physical examination? | 179 | ||
4. Why are a normal reticulocyte count and a normal complete blood count important in the diagnostic workup for this neonate? | 179 | ||
5. What is the most serious complication of neonatal jaundice and how does it develop? | 179 | ||
Case7-4 continued: | 180 | ||
6. Are there long-term risks associated with physiologic jaundice of the newborn? | 180 | ||
7. Would you expect physiologic jaundice to be exacerbated or attenuated by Gilbert's syndrome? | 180 | ||
8. What is the hereditary syndrome with a more serious deficiency of uridine diphosphate | 180 | ||
9. What are the hereditary forms of conjugated hyperbilirubinemia and what is the major histologic difference between them? | 180 | ||
Case7-5 | 183 | ||
1. To what ailments are persons infected with hepatitis B susceptible? | 183 | ||
Chapter 8: Endocrinology | 196 | ||
Basic concepts | 196 | ||
1. What is the cellular mechanism of action of the steroid hormones? | 196 | ||
2. What is the cellular mechanism of action of the peptide hormones and the catecholamines? | 196 | ||
3. Why is the total serum hormone level not an accurate reflection of hormone activity? | 196 | ||
4. How does a hormone's binding to the same type of receptor have different effects in different cell types? | 198 | ||
5. What are the four primary classes of membrane-spanning receptors to which peptide hormones bind? | 198 | ||
6. How do the tyrosine kinase receptors transduce their messages? | 199 | ||
7. How do the ligand-gated ion channels work? | 199 | ||
8. How do the G proteins transduce their signals? | 199 | ||
9. How do endocrine, paracrine, and autocrine mechanisms of cell communication differ? | 200 | ||
10. Describe the concept of negative feedback. What is a feedback loop? | 200 | ||
Case8-1 | 201 | ||
1. What is the diagnosis? | 202 | ||
2. Why is the pituitary more susceptible to infarction in postpartum hemorrhage than in hemorrhagic shock unrelated to pregn... | 202 | ||
3. Why is the posterior pituitary typically spared in Sheehan's syndrome? | 202 | ||
4. Secretion of which pituitary hormones may be affected in this woman? | 202 | ||
5. Why may hypothalamic releasing hormone secretion increase because of an infarction of the anterior pituitary? | 203 | ||
6. Why wouldn't hypothalamic dopamine secretion be elevated from an anterior pituitary infarction? | 205 | ||
Case8-2 | 207 | ||
1. What is the diagnosis? | 207 | ||
2. What are the normal physiologic functions of prolactin preceding, during, and following pregnancy? | 207 | ||
3. Why does this patient have galactorrhea, whereas pregnant women with similar levels of serum prolactin | 207 | ||
4. Hyperprolactinemia can also occur in men. What symptoms might be expected in men? | 207 | ||
5. How does elevated prolactin prevent pregnancy (i.e., what is the mechanism of infertility and amenorrhea in this patient)? | 209 | ||
6. Why is asking about a history of schizophrenia and use of antipsychotic medications a relevant question in the diagnostic.. | 209 | ||
7. What is the mechanistic basis for using bromocriptine (used to treat Parkinson's disease) in the treatment of a prolactin... | 209 | ||
8. How can head trauma with a severed pituitary stalk cause a similar increase in prolactin (assuming the anterior pituitary... | 209 | ||
9. Why does hypothyroidism need to be considered in the evaluation of hyperprolactinemia? | 209 | ||
Case8-3 | 210 | ||
1. What is the diagnosis? | 210 | ||
2. Why is hyperglycemia commonly associated with this disease? | 210 | ||
3. What are the normal physiologic functions of growth hormone and how is its secretion regulated? | 210 | ||
4. Given the normal physiology of growth hormone, how can we explain this patient's presentation? | 211 | ||
5. Why is octreotide, a somatostatin analog, useful in the treatment of acromegaly? | 211 | ||
6. If this patient developed a growth hormone-secreting tumor in his early teens, how might the clinical manifestations... | 212 | ||
7. What growth abnormality results from deficient secretion of growth hormone during the growing years? | 212 | ||
Case8-4 | 212 | ||
1. What are the general causes of the hormonal abnormality most likely present in this woman? | 212 | ||
Case8-4 continued: | 213 | ||
2. What is the cause of the hypercortisolism in this patient? | 213 | ||
3. Why are the results of a dexamethasone suppression test read at a specific time of day? | 213 | ||
4. Why has hirsutism developed in this woman? | 213 | ||
5. Why isn't hyperaldosteronism typically seen in Cushing disease? | 214 | ||
6. What morphologic feature of the adrenal glands would you expect to see in this woman? | 214 | ||
7. How is hypercortisolism contributing to hyperglycemia in this patient? | 214 | ||
8. How is hypercortisolism contributing to hypertension and hypokalemia in this patient? | 214 | ||
9. Why doesn't cortisol have mineralocorticoid actions in the normal physiologic setting? | 214 | ||
10. What would an x-ray study of her bones likely reveal? | 215 | ||
11. What are the three layers of the adrenal cortex, and which one is responsible for the excess production of cortisol in... | 215 | ||
12. One treatment for Cushing disease is to remove both adrenal glands (bilateral adrenalectomy). What might happen to the... | 215 | ||
Case8-5 | 216 | ||
1. What do you suspect at this point? | 216 | ||
2. What are some general causes of primary adrenal insufficiency (Addison's disease)? | 217 | ||
Case8-5 continued: | 217 | ||
3. What was the cause of adrenal insufficiency in this patient? | 217 | ||
Related Questions | 217 | ||
4. What adrenal disease should be suspected in a young patient with bacterial meningitis due to Neisseria meningitidis who... | 217 | ||
5. How would we expect plasma aldosterone levels to be affected in a patient with secondary | 217 | ||
Case8-6 | 218 | ||
1. What do you suspect at this point? | 218 | ||
2. Why does hypertension often worsen after starting a beta blocker in patients with pheochromocytoma? | 218 | ||
Case8-6 continued: | 218 | ||
3. What is the likely diagnosis? | 218 | ||
4. How can the administration of clonidine be used to differentiate pheochromocytoma from a ``high-stress state´´? | 219 | ||
5. What is the ``rule of 10s´´ for pheochromocytomas? | 219 | ||
6. What malignant tumor that most often occurs in children under 5years of age also shows increased | 219 | ||
Case8-6 continued: | 219 | ||
7. What type of receptors do norepinephrine and epinephrine bind to on the heart to increase the rate and force of cardiac co.. | 219 | ||
8. Why was this patient given propranolol, a nonselective beta blocker, if it can cause a hypertensive crisis? | 220 | ||
9. On a related note, what class of antihypertensive agent, if given prior to epinephrine, would make it so that epinephrine... | 220 | ||
Case8-6 continued: | 220 | ||
10. Why was phenoxybenzamine given prior to surgery? | 220 | ||
Case8-7 | 221 | ||
1. What do you suspect at this point? | 221 | ||
Case8-7 continued: | 221 | ||
2. What is the diagnosis? | 221 | ||
3. Why has this woman experienced weight loss? | 223 | ||
4. What are the two thyroid hormones and which is more potent? | 224 | ||
5. How are the thyroid hormones synthesized? | 224 | ||
6. Assuming the plasma levels of catecholamines are normal in this patient, what explains the tachycardia, tremors, palpitati | 224 | ||
7. What is the difference between primary, secondary, and tertiary hyperthyroidism and which does this patient have? | 224 | ||
8. Based on your suspected diagnosis, what additional laboratory and physical findings might you expect? | 225 | ||
Case8-7 continued: | 225 | ||
9. What is the pathophysiology of this complication of Graves´ disease? | 225 | ||
10. What would a thyroid iodide-131 uptake scan likely reveal in this patient? | 225 | ||
11. What therapeutic options are available to this patient? | 227 | ||
12. Why might a physician prescribe propylthiouracil or methimazole for this woman? How do these drugs work? | 227 | ||
13. What is thyroid storm? Why is propylthiouracil used for this condition instead of methimazole? | 228 | ||
14. Why is iodide therapy generally initiated 2weeks prior to thyroidectomy in hyperthyroid patients? | 228 | ||
Some Differential Diagnosis and Physiology Concepts | 228 | ||
15. How would a patient with hyperthyroidism secondary to de Quervain's thyroiditis (subacute granulomatous thyroiditis) typi | 228 | ||
16. How can a teratoma produce hyperthyroidism? | 228 | ||
Case8-8 | 229 | ||
1. What do you suspect at this point? | 229 | ||
Case8-8 continued: | 229 | ||
2. Why was asking about lithium use relevant in the diagnostic workup of this patient? | 229 | ||
Chapter 9: Male and Female Reproductive Systems | 252 | ||
Basic concepts | 252 | ||
1. What is the normal duration of the menstrual cycle? What are the two ovarian phases, and which occurs first? | 252 | ||
2. Which phase of the ovarian cycle is generally responsible for the cycle being longer or shorter? | 252 | ||
3. During the follicular phase, what hormonal changes occur in the pituitary and the ovary?: | 252 | ||
4. What occurs in the uterus during the follicular phase? | 253 | ||
5. What happens to cause ovulation at the end of the follicular phase? | 253 | ||
6. What happens in the ovary and endometrium during the luteal phase? | 254 | ||
7. In women with amenorrhea (absence of menses), why does bleeding after the cessation of a brief course of progesterone indi | 255 | ||
8. How does fertilization prevent degeneration of the corpus luteum? | 255 | ||
9. How does the corpus luteum function in the maintenance of pregnancy? | 255 | ||
10. Describe the hormones associated with normal testicular descent. | 255 | ||
11. What is the function of the SRY gene? | 255 | ||
12. What is hermaphroditism? | 255 | ||
13. What is 5α-reductase deficiency? | 256 | ||
Case9-1 | 257 | ||
1. What important information should you find out before prescribing hormonal contraceptives? | 257 | ||
Case9-1 continued: | 257 | ||
2. What are you concerned about in this woman's history in regard to hormonal contraception? | 257 | ||
3. What are the absolute contraindications to using estrogen-containing contraceptives? | 257 | ||
4. What do oral contraceptives typically consist of and what is their mechanism of action? | 257 | ||
5. How can menstrual cycles be made regular by hormonal contraceptives? | 258 | ||
6. Your patient asks if taking hormonal contraceptives will increase her risk for endometrial cancer. How does taking oral co | 258 | ||
7. How do ovarian cysts form and how do oral contraceptives reduce their occurrence? | 258 | ||
8. Why may the drugs phenytoin, phenobarbital, and rifampin make oral contraceptives less effective at preventing pregnancy? | 258 | ||
Case9-2 | 259 | ||
1. What is the differential diagnosis for secondary amenorrhea? | 259 | ||
Chapter 10: Oncology | 291 | ||
Basic concepts-cell biology of cancer | 291 | ||
1. What is the difference between an oncogene and a tumor suppressor gene? | 291 | ||
2. Which type of mutation is more commonly involved in familial cancer syndromes? | 291 | ||
3. How does Knudson's ``two-hit hypothesis´´ relate to tumor suppressor genes? | 291 | ||
4. What are the phases of the cell cycle? Where is the restriction point? | 292 | ||
5. What is the function of checkpoints and cell cycle arrests? | 292 | ||
6. What is the importance of p53? | 293 | ||
7. What is the function of the retinoblastoma protein? | 293 | ||
8. When can a solid tumor be detected clinically? | 293 | ||
9. What is the importance of angiogenesis in solid tumor growth? | 293 | ||
10. What is dysplasia? What is anaplasia? | 294 | ||
Basic concepts-cancer epidemiology | 294 | ||
11. What are three leading causes of death in the United States? | 294 | ||
12. Aside from skin cancer, which cancers have the highest incidence in men and in women? Which cancers are the leading cause | 294 | ||
Basic concepts-cancer classification | 294 | ||
13. What is the difference between ``grade´´ and ``stage´´ of a neoplasm? | 294 | ||
14. What is the difference between a benign tumor and a malignant tumor? | 295 | ||
15. How are cancers named according to the cell type they originate from? | 295 | ||
Case10-1 | 295 | ||
1. What is dyspepsia? | 296 | ||
2. What is the differential diagnosis for dyspepsia? | 296 | ||
Chapter 11: Genetic and Metabolic Disease | 329 | ||
Basic Concepts | 329 | ||
1. What is an enzymopathy and how does it result in clinical symptoms? | 329 | ||
2. What is the typical pattern of inheritance observed in enzymopathies? | 330 | ||
3. Explain why the pathologic consequences of X-linked enzymopathies are manifested almost exclusively in males. | 330 | ||
4. What is the process of lyonization and how may it cause the manifestation of X-linked diseases in females? | 330 | ||
5. Why do some diseases show an autosomal dominant pattern of inheritance? Why do the genetic diseases of connective tissue u | 331 | ||
6. What is the general relationship between the function of a protein and its pattern of inheritance? | 331 | ||
7. What are the following molecular biology diagnostic methods used for? Explain briefly how they work. | 331 | ||
Case11-1 | 332 | ||
1. What is the most likely diagnosis in this baby and how is it inherited? | 333 | ||
2. What is the major defect and underlying pathophysiology of this disorder? | 333 | ||
3. How is phenylketonuria treated? | 334 | ||
4. Given the fact that phenylketonuria is a relatively rare condition (prevalence rates range from 1 in 2600 to 1 in 200,000 | 334 | ||
5. If the parents have a female child with this disease, why is it crucial to advise the child about the risks to her baby if | 334 | ||
Related Question | 334 | ||
6. Why is screening for congenital hypothyroidism (cretinism), congenital adrenal hyperplasia, and galactosemia also routinel | 334 | ||
Case11-2 | 335 | ||
1. If the parents decide to have another child, what is the probability of that child having cystic fibrosis? | 335 | ||
2. If the parents want to have another child, what kind of genetic screening methods are available for them to consider? | 335 | ||
3. Despite having mutations in the same gene, why do patients with cystic fibrosis exhibit significant variability in disease | 335 | ||
4. Assuming a cystic fibrosis prevalence rate of 1 in 2500, what is the carrier frequency for this disease? | 336 | ||
Case11-3 | 336 | ||
1. What two diagnoses are top considerations in the differential diagnosis at this point? | 337 | ||
Case11-3 continued: | 337 | ||
2. Now what is the most likely diagnosis? | 337 | ||
3. What is the pathogenesis of Tay-Sachs disease? | 337 | ||
4. Which is the most common sphingolipidosis? | 337 | ||
5. What are the mucopolysaccharidoses? | 338 | ||
6. Quick review: Cover the three columns on the right side of Table11-3 and attempt to describe the enzyme deficiency, accu | 338 | ||
Case11-4 | 340 | ||
1. What is the most likely diagnosis? | 340 | ||
2. What is the normal function of the purine ``salvage´´ pathway? | 340 | ||
3. How do defects in the purine salvage pathway cause hyperuricemia? | 341 | ||
4. What was the orange ``sand´´ in his diapers observed by his parents? | 341 | ||
5. Why do boys with Lesch-Nyhan syndrome typically present with renal dysfunction? | 342 | ||
6. How might this patient be managed pharmacologically? | 342 | ||
Case11-5 | 342 | ||
1. What is the diagnosis? | 343 | ||
2. What type of enzymatic deficiency is present in all types of glycogen storage diseases? | 343 | ||
3. How is glycogen normally synthesized and degraded in the liver? | 343 | ||
4. What is the function of glucose-6-phosphatase? | 344 | ||
5. Why is hepatomegaly seen on examination? | 344 | ||
6. What is the explanation for his severe fasting hypoglycemia and lactic acidosis? | 344 | ||
7. Why is this patient susceptible to hypertriglyceridemia? | 344 | ||
8. What causes the hyperuricemia in this patient? | 345 | ||
9. Quick review: Cover the columns on the right side of Table11-4 and explain how these diseases affect the activity of the | 345 | ||
Related Questions | 346 | ||
10. Why does a deficiency of muscle glycogen phosphorylase (seen in type V glycogen storage disease, or McArdle disease) not | 346 | ||
11. Review the high-yield glycogen storage diseases. | 346 | ||
Case11-6 | 348 | ||
1. What is the most likely diagnosis? | 348 | ||
2. What are the three length classifications of fatty acids? | 348 | ||
3. What are the reasons for the clinical and laboratory findings exhibited by this patient? | 348 | ||
4. How should this child be treated? | 349 | ||
5. How are the pathways/cycles listed in Table11-6 affected by medium-chain fatty acyl-CoA dehydrogenase deficiency? | 349 | ||
Case11-7 | 350 | ||
1. What are the porphyrias? | 350 | ||
2. What are the types of porphyria? | 350 | ||
3. Why may cigarette smoking or anticonvulsants such as phenytoin and phenobarbital trigger acute porphyrias? | 351 | ||
4. Why is hemin or glucose given to patients with acute porphyrias? | 351 | ||
Related Questions | 351 | ||
5. How does lead poisoning affect heme synthesis? | 351 | ||
6. What are the sideroblastic anemias? | 351 | ||
Case11-8 | 352 | ||
1. What is the diagnosis? | 352 | ||
2. Why does galactose-1-phosphate uridyltransferase deficiency manifest with jaundice? | 353 | ||
3. Why do infants with galactosemia tend to develop cataracts if left untreated? | 353 | ||
4. What is the treatment for classical galactosemia? | 353 | ||
Case11-9 | 354 | ||
1. What is the diagnosis? | 354 | ||
2. Why does this patient exhibit multiple pathologic presentations in the ocular, skeletal, and cardiovascular systems? | 354 | ||
3. What pathologic condition would you suspect in a patient with Marfan syndrome who complains about ``the worst headache of | 355 | ||
4. What are the major cause(s) of death in this disorder? | 355 | ||
Related Questions | 355 | ||
5. What hereditary skeletal disease predisposes to bone fractures from minor stress? What structural protein defect underlies | 355 | ||
6. What is the genetic defect in Ehlers-Danlos syndrome? | 355 | ||
Case11-10 | 356 | ||
1. What is the most likely diagnosis? | 356 | ||
2. What is the etiology of this disease? | 356 | ||
3. How does the cystic fibrosis transmembrane regulator (CFTR) mutation lead to disease? | 356 | ||
4. Why does this child develop respiratory infections so easily? | 357 | ||
5. Why might this child be susceptible to developing pancreatitis as he grows older? | 357 | ||
6. What is bronchiectasis and why does it commonly develop in cystic fibrosis? | 357 | ||
7. Why is N-acetylcysteine used as a treatment for cystic fibrosis? | 357 | ||
Related Questions | 358 | ||
8. Why does Kartagener's syndrome produce clinical manifestations similar to those of cystic fibrosis? | 358 | ||
Case11-11 | 359 | ||
1. What is your diagnosis based on this patient's family history and fasting lipid profile? | 359 | ||
2. Based on his clinical presentations, is this patient likely to be heterozygous or homozygous for this deficiency? | 359 | ||
3. What is the primary mechanism by which mutations in the low-density lipoprotein receptor impair low-density lipoprotein up | 360 | ||
4. What is the pathologic consequence of elevated plasma low-density lipoprotein? | 360 | ||
5. How might this patient be managed medically and pharmacologically to decrease his risk of future cardiovascular complicati | 360 | ||
Related Question | 361 | ||
6. How do HMG-CoA reductase inhibitors specifically reduce serum low-density lipoprotein levels? | 361 | ||
Case11-12 | 361 | ||
1. What is the most likely diagnosis? | 361 | ||
2. What is the pathogenesis of this disorder? | 362 | ||
3. Southern blot analysis indicates that his mother has 90 CGG trinucleotide repeats, whereas he has 350 CGG repeats. What ac | 362 | ||
Related Question | 363 | ||
4. What other relatively common inherited disorder exhibits genetic anticipation? | 363 | ||
Case11-13 | 363 | ||
1. What is the most likely diagnosis? | 364 | ||
2. What is a robertsonian translocation and how does a robertsonian translocation in a parent result in Down syndrome in the | 364 | ||
3. What is the mechanism that gives rise to mosaic Down syndrome, whereby only select tissues express the trisomy 21? | 364 | ||
4. If the child were to fail to initiate proper feeding, what abnormality should be suspected? | 364 | ||
5. What causes most of the deaths in infancy and in childhood in Down syndrome? | 365 | ||
6. Which cancer types are associated with Down syndrome? | 365 | ||
7. What characteristic neuropathologic changes are seen in brains of older people (i.e., >40years of age) with Down syndrome? | 365 | ||
Related Questions | 365 | ||
8. What other two autosomal trisomies can sometimes produce live-born infants? | 365 | ||
9. What two diseases result from microdeletion of the same section of chromosome 15? | 365 | ||
10. Why is the parental source of the chromosome significant in the aforementioned microdeletion syndromes? | 366 | ||
Case11-14 | 367 | ||
1. What is the (noncardiac) diagnosis in this patient? | 367 | ||
2. What is the reason for his elevated urinary urea nitrogen excretion? | 367 | ||
3. What is the reason for the low serum albumin level? | 368 | ||
4. Would you expect this patient to have an obviously emaciated appearance and muscle wasting? | 368 | ||
5. What are some potential dangers if this condition is left treated? | 368 | ||
6. Compare and contrast marasmus and kwashiorkor | 368 | ||
Case11-15 | 369 | ||
1. What is the likely diagnosis in this patient? | 369 | ||
2. What are the symptoms of vitamin A toxicity? | 370 | ||
3. What are the symptoms associated with vitamin A deficiency? | 370 | ||
Chapter 12: Anemias | 371 | ||
Basic concepts | 371 | ||
1. What is anemia and how is it defined? | 371 | ||
2. What are the three pathophysiologic mechanisms resulting in anemia? | 372 | ||
2. What are reticulocytes? What is a normal reticulocyte count? | 372 | ||
3. What are the hemolytic anemias and how are they typically classified? | 372 | ||
4. Regarding hemolytic anemia, what is the difference between intravascular and extravascular hemolysis? | 373 | ||
5. Why is there a greater degree of hemoglobinemia and hemoglobinuria in intravascular hemolysis than in extravascular hemoly | 373 | ||
6. How are microcytic, macrocytic, and normocytic anemias defined? | 373 | ||
7. What is the usual cause of anemia in end-stage renal failure? | 374 | ||
Case12-1 | 374 | ||
1. What is the differential diagnosis for normocytic anemia? | 374 | ||
Case12-1 continued: | 374 | ||
2. What is the expected diagnosis now and what is the confirmatory test? | 375 | ||
Chapter 13: Bleeding Disorders | 404 | ||
Basic Concepts | 404 | ||
1. Differentiate between the processes of primary and secondary hemostasis. | 404 | ||
2. What molecule is responsible for the binding of platelets to collagen? | 404 | ||
3. What constitutes the extrinsic, intrinsic, and common pathways in the coagulation cascade that forms the fibrin clot (seco | 404 | ||
4. What information can be provided by measuring the prothrombin time and activated partial thromboplastin time? | 405 | ||
5. What is the bleeding time? What is its clinical significance? | 405 | ||
6. What is the mechanism of action of the following drugs? How do they affect the times just discussed? | 405 | ||
7. What is the mechanism of action of tissue plasminogen activator? | 407 | ||
Case13-1 | 408 | ||
1. What is the most likely diagnosis? | 408 | ||
2. What is the cause of this disorder and how is it inherited? | 408 | ||
3. Which measure of coagulation will be abnormal in hemophilia A? | 409 | ||
4. What is the mainstay of medical treatment for this disease? | 409 | ||
Case13-2 | 409 | ||
1. What is the most likely diagnosis? | 409 | ||
2. What is the pathogenesis of disseminated intravascular coagulation? | 410 | ||
3. What are schistocytes and why do they form in disseminated intravascular coagulation? | 410 | ||
4. How does the pathophysiology of thrombotic thrombocytopenic purpura differ from that of disseminated intravascular coagula | 410 | ||
5. What is the pentad of thrombotic thrombocytopenic purpura and how does this disorder differ from hemolytic uremic syndrome | 411 | ||
6. Quick review: Cover the two columns at the right in Table13-3 and try to differentiate thrombotic thrombocytopenic purpu | 411 | ||
Case13-3 | 412 | ||
1. What is the most likely diagnosis? | 412 | ||
2. What is the normal function of von Willebrand factor and what is the pathogenesis of this man's disease? | 412 | ||
3. Why may someone with von Willebrand disease be mistakenly diagnosed with hemophilia A? | 413 | ||
4. What is the mechanism of action whereby administration of desmopressin acetate might help this man's symptoms? | 413 | ||
Differential Diagnosis | 413 | ||
5. If this man had normal levels of functional von Willebrand factor, and platelet function studies revealed a defect in plat | 413 | ||
6. If platelet function studies demonstrated platelets capable of adhering to collagen but unable to aggregate with other pla | 413 | ||
7. Given the previously mentioned function of the GPIIb-IIIa receptor, why are drugs such as abciximab (Integrilin) given to | 414 | ||
8. Why might you suspect an abnormal bleeding time in this man if he suffered from diabetic nephropathy and osteoarthritis fo | 414 | ||
9. Quick review: Cover the two columns on the right side of Table13-4 and try to describe the mechanisms of action for the | 414 | ||
Case13-4 | 415 | ||
1. What is the most likely diagnosis in this woman? | 415 | ||
2. What is the etiology of immune thrombocytopenic purpura? | 415 | ||
3. Would a bone marrow biopsy in this woman likely reveal increased or decreased numbers of megakaryocytes and why? | 415 | ||
4. What anticoagulant is well known for causing thrombocytopenia? | 415 | ||
5. Why is the absence of splenomegaly important and therefore helpful in determining the cause of thrombocytopenia? | 415 | ||
6. Can pregnant women with this disease affect the platelet count of their fetuses? | 416 | ||
7. What is the treatment strategy for this disease? | 416 | ||
Case13-5 | 416 | ||
1. What is the diagnosis? | 416 | ||
2. From what site do deep venous thromboses, which give rise to pulmonary embolisms, typically arise? | 417 | ||
3. What is Virchow's triad and how does this relate to this patient? | 417 | ||
4. How do deficiencies of proteins C and S and antithrombin III predispose to deep venous thrombosis? | 417 | ||
5. What is antiphospholipid syndrome? | 417 | ||
Chapter 14: Hematologic Malignancies | 418 | ||
Basic Concepts | 418 | ||
1. What are the two principal lineages along which leukocytes differentiate? | 418 | ||
2. What categories of hematologic malignancy arise from the lymphoid lineage? | 419 | ||
3. What is the general distinction between lymphoma and leukemia? | 419 | ||
4. What is the distinction between small cell lymphocytic lymphoma (SLL) and (B-cell) chronic lymphocytic leukemia (B-CLL)? | 419 | ||
5. What categories of hematologic neoplasms arise from the myeloid lineage? | 419 | ||
6. What is the distinctive feature of acute myelogenous leukemia on bone marrow biopsy? | 419 | ||
7. What is the distinctive feature of myelodysplastic syndromes? | 420 | ||
8. What is the distinct feature of the myeloproliferative disorders? | 420 | ||
9. What are the histiocytoses? | 420 | ||
10. What is the relationship between myelofibrosis and the myeloproliferative diseases? | 420 | ||
11. How does the leukocyte alkaline phosphatase level help differentiate reactive leukocytosis from a true leukemia? | 421 | ||
12. Quick review! Cover the right column in Table14-1 and attempt to list the cell type and pertinent high-yield facts reg | 421 | ||
13. Quick review! Cover the right column in Table14-2 and attempt to define the hematologic terms in the left column. | 421 | ||
14. What are the genetic alterations in the following non-Hodgkin's lymphomas? | 422 | ||
15. What are some characteristics of the other non-Hodgkin's lymphomas? | 423 | ||
16. Quick review with high-yield word associations: Cover the right column of Table 14-5 and attempt to list the associated d | 423 | ||
Case14-1 | 423 | ||
1. What is the differential diagnosis for back pain in an older patient? | 424 | ||
Case14-1 continued: | 424 | ||
2. What is the expected diagnosis? | 424 | ||
3. What blood abnormalities often present with multiple myeloma and why? | 424 | ||
Case14-1 continued: | 425 | ||
4. What cell type abnormally proliferates in multiple myeloma? | 425 | ||
5. What is the association between Bence Jones proteinuria and the previously mentioned monoclonal gammopathy? | 425 | ||
6. What is amyloidosis and why is this man at risk for developing it? | 426 | ||
7. Explain why this man is at an increased risk for infection even though plasma levels of immunoglobulins are abnormally ele | 426 | ||
8. This patient's anemia can be characterized as myelophthisis. Why? | 426 | ||
9. What is the characteristic finding on a peripheral blood smear, as shown in Figure14-3, and why does this occur? | 426 | ||
10. How might the presence of elevated serum κ light chains and amyloidosis affect kidney function in this patient? | 426 | ||
11. What is the pharmacologic basis for giving this patient allopurinol prior to and during chemotherapy? | 426 | ||
Differential Diagnosis | 427 | ||
12. If workup reveals an IgM monoclonal gammopathy rather than an IgG or IgA gammopathy, what disease might you suspect? | 427 | ||
Case14-2 | 427 | ||
1. Her parents are worried she might have cancer. What is the most common cancer in children? | 427 | ||
Chapter 15: Immunology | 439 | ||
Basic Concepts | 439 | ||
1. Outline hematopoiesis, beginning with a pluripotent stem cell. | 439 | ||
2. What are the major primary and secondary organs that make up the human lymphoid system? | 439 | ||
3. What is the function of innate immune system? | 439 | ||
4. What is adaptive/acquired immunity? | 440 | ||
5. What are the basic characteristics of cell-mediated and humoral immunity? | 440 | ||
6. Describe the difference between class I and class II major histocompatibility complex molecules. | 441 | ||
7. How do antibodies eliminate extracellular pathogens? | 442 | ||
8. By what process can antibodies catalyze the elimination of intracellular pathogens? | 442 | ||
9. What are the five classes (isotypes) of immunoglobulins? Describe their respective distributions in the body. | 442 | ||
10. Most humans can produce 106 to 109 unique immunoglobulin (Ig) molecules. However, the number of immunoglobulin genes is o | 442 | ||
11. What are complement proteins and how do they function in an immune response? | 444 | ||
12. Describe the ramifications of the most common complement protein deficiencies. | 444 | ||
13. Which complement components and cytokines are required for neutrophil chemotaxis? | 444 | ||
14. As a review, list the effector functions of the major leukocyte classes. | 445 | ||
15. List the functions of the major cytokines secreted by various classes of immune cells. | 449 | ||
16. List the major cell surface markers used to identify various classes of immune cells. | 449 | ||
Case15-1 | 449 | ||
1. What is the differential diagnosis for this presentation? | 449 | ||
Case15-1 continued: | 449 | ||
2. What is the most likely diagnosis? | 449 | ||
3. Can free penicillin cause anaphylaxis? | 450 | ||
4. What type of hypersensitivity is anaphylaxis? What is its immunopathogenesis? | 450 | ||
5. What is the pathophysiologic explanation for the wheezing and diarrhea that developed? | 451 | ||
6. How does anaphylaxis result in the urticaria observed in this patient? | 451 | ||
7. Why did the child NOT have a reaction to amoxicillin when it was first administered for his previous ear infection? | 451 | ||
8. What clinical testing can be performed to confirm that this immediate hypersensitivity reaction was caused by amoxicillin? | 451 | ||
9. Why was the child immediately given epinephrine? | 451 | ||
10. Why was the child given diphenhydramine and methylprednisolone? | 451 | ||
Related Questions | 452 | ||
11. What was the motivation for developing the second-generation H1 receptor antagonists such as fexofenadine (Allegra) and l | 452 | ||
12. List the common classes of drugs that are used to treat type I hypersensitivity disorders and their general mode of actio | 452 | ||
Case15-2 | 452 | ||
1. What is the differential diagnosis for this presentation? | 452 | ||
2. What additional tests should be ordered to further analyze the anemia and jaundice? | 452 | ||
Case15-2 continued: | 454 | ||
3. What is the most likely diagnosis? | 454 | ||
4. What is the significance of a positive direct Coombs´ test and how does it support the diagnosis considered in this pati | 454 | ||
5. How do medications such as penicillin cause autoimmune hemolytic anemia? | 454 | ||
6. What type of hypersensitivity does autoimmune hemolytic anemia represent? | 454 | ||
7. What is the mechanism by which hemolysis occurs in drug-induced autoimmune hemolytic anemia? | 454 | ||
Related Question | 455 | ||
8. If this patient had had a Mycoplasma pneumoniae infection rather than a pneumococcal infection, what type of autoimmune he | 455 | ||
Case15-3 | 455 | ||
1. What is the differential diagnosis for this boy's presentation? | 455 | ||
Case15-3 continued: | 455 | ||
2. What is the most likely diagnosis? | 455 | ||
3. What is the pathogenesis of serum sickness? | 456 | ||
4. What is the reason for the delay from the serum administration to the onset of symptoms? | 456 | ||
5. What is the significance of decreased serum levels of complement? | 456 | ||
6. What caused the hives and facial swelling in the patient? | 456 | ||
7. What is the significance of red blood cells and protein in the urine? | 456 | ||
8. What is the cause of this boy's joint pain? | 457 | ||
9. Does a type III hypersensitivity reaction require previous exposure (sensitization) to antigen to occur? | 457 | ||
10. Why has the increasing use of antibody therapy NOT led to a sharp increase in the incidence of immune complex-mediated | 457 | ||
Case15-4 | 457 | ||
1. What is the differential diagnosis for this woman's rash? | 457 | ||
2. How can allergic type and irritant type contact dermatitis be differentiated? | 458 | ||
Case15-4 continued: | 458 | ||
3. What is the diagnosis? | 458 | ||
4. What is the causative agent and the mechanism by which it induced an immune response in the patient? | 458 | ||
5. Why did the patient have lesions in areas other than on her arms and upper chest (where she applied the spray)? | 458 | ||
6. What is the treatment for allergic type contact dermatitis? | 459 | ||
7. Why is it important for the patient to avoid the use of benzocaine in the future? | 459 | ||
Case15-5 | 459 | ||
1. What is the differential diagnosis? | 459 | ||
Case15-5 continued: | 459 | ||
2. What is the most likely diagnosis in this infant, given the fact that specialized testing revealed defects in both cellula | 461 | ||
3. Why might a bone marrow transplant from an appropriate donor cure this boy? | 461 | ||
4. What is the significance of the marked lymphopenia and complete lack of CD3 cells? | 461 | ||
5. Why are B-cell defects not evident in many babies when they are first diagnosed with severe combined immunodeficiency? | 461 | ||
6. Mutations in the γ subunit of the IL-2 receptor are found in the most common, X-linked form of severe combined immun | 461 | ||
Related Questions: B-Cell Disorders | 462 | ||
7. Which primary immunodeficiency should be suspected in a child with normal cell-mediated immunity but almost complete absen | 462 | ||
8. Which B-cell disorder is associated with anaphylactic transfusion reactions? | 462 | ||
Case15-6 | 463 | ||
1. What is the differential diagnosis for this boy's apparent immunodeficiency? | 463 | ||
Case15-6 continued: | 463 | ||
2. What is the diagnosis? | 463 | ||
3. What are the two mechanisms that a macrophage can employ to kill bacteria following phagocytosis? | 464 | ||
4. What is the genetic basis of chronic granulomatous disease? | 464 | ||
5. What are the contents of a granuloma and why is it formed? | 464 | ||
6. Patients with chronic granulomatous disease often experience recurrent staphylococcal infections, but streptococcal infect | 464 | ||
7. What is the mechanism of action of amphotericin B? | 464 | ||
8. How does liposomal amphotericin B differ from amphotericin B? | 465 | ||
Related Questions: Phagocyte Disorders | 465 | ||
9. How does Chédiak-Higashi syndrome differ from chronic granulomatous disease? | 465 | ||
10. Compare and contrast monocytes and macrophages with respect to origin, location, lifespan, and function. | 466 | ||
Case15-7 | 469 | ||
1. What is the likely diagnosis in this infant and what is the pathophysiology of her disorder? | 469 | ||
2. Joseph Heller might ask, ``What tried and true medical school mnemonic can be used to remember the classic manifestations | 469 | ||
3. To what type of infections might this child be vulnerable, given that thymic development is abnormal? | 469 | ||
4. What might a lymph node biopsy in this infant reveal? | 470 | ||
Related Question | 470 | ||
5. What does the process of ``thymic education´´ involve? | 470 | ||
Case15-8 | 470 | ||
1. What is the differential diagnosis? | 470 | ||
Chapter 16: Psychology | 486 | ||
Case16-1 | 486 | ||
1. What is the most likely diagnosis? | 486 | ||
2. According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), what criteria must be met in order to mak | 486 | ||
3. What is the diagnosis if this man had suffered these symptoms for only the past 3months rather than for 8months (with a ne | 487 | ||
4. What is the likely diagnosis if this man presented with these symptoms and later developed depressive, manic, or mixed fea | 487 | ||
5. What would your diagnosis be if this man had symptoms of schizophrenia following a severe stressor and these symptoms reso | 487 | ||
6. What are the four primary types of schizophrenia? | 488 | ||
7. What neurotransmitter abnormality is thought to play the primary role in this man's disorder? | 488 | ||
8. What are the differences between the positive and negative symptoms experienced by schizophrenics? | 488 | ||
9. What is the relationship between schizophrenia and suicide? | 488 | ||
10. When initiating therapy for patients like this college student, it is important to keep potential side effects in mind an | 489 | ||
11. What is the correct treatment for the previously mentioned extrapyramidal side effects? | 489 | ||
12. How might this man develop the following symptoms if he is being treated with low-potency typical antipsychotics such as | 489 | ||
13. Perhaps the most feared complication of antipsychotics is an idiosyncratic reaction characterized by severe muscle rigidi | 490 | ||
14. How do typical and atypical antipsychotics differ with respect to their mode of action and to their effect on positive an | 490 | ||
15. Which one of the four major dopamine pathways of the brain is responsible for the following symptoms in schizophrenia? | 490 | ||
16. Recent studies have suggested that there is no large difference in effectiveness and tolerability between the typical and | 491 | ||
17. Why is clozapine recommended for use only in schizophrenics whose symptoms are refractory to treatment with other antipsy | 491 | ||
Case16-2 | 492 | ||
1. What is the diagnosis? | 492 | ||
2. Was the previous depressive episode required to make the diagnosis of bipolar in ``Roller-coaster´´? | 493 | ||
3. The physician prescribes lithium and informs ``Roller-coaster´´ that he needs to have his blood levels of lithium | 493 | ||
4. After taking lithium for an extended period of time, ``Roller-coaster´´ develops polyuria and polydipsia. The urin | 493 | ||
5. True or false: Treatment of this lithium-induced nephrogenic diabetes insipidus with loop diuretics may be effective in de | 493 | ||
6. ``Roller-coaster´´ also mentions that he has become rather depressed after being on the lithium for a while, is havi | 493 | ||
7. Because ``Roller-coaster´´ is not tolerating lithium well, his physician decides to substitute a drug that is effe | 493 | ||
8. At his next visit, ``Roller-coaster's´´ symptoms seem to be well controlled with valproic acid, but his liver enzy | 494 | ||
9. Why should valproic acid be used with extreme caution in patients also taking phenobarbital? | 494 | ||
10. In someone with a seizure disorder that is well controlled with phenytoin, why may the addition of carbamazepine cause se | 494 | ||
Case16-3 | 494 | ||
1. What is the most likely diagnosis? | 495 | ||
2. According to the DSM-IV, what criteria must be met in order to make the diagnosis of major depressive disorder? | 495 | ||
3. What does the monoamine deficiency theory propose with respect to the etiology of depression? | 495 | ||
4. Why does hypothyroidism have to be ruled out in this patient? | 495 | ||
5. What pharmacologic therapies are available to treat depression? | 495 | ||
6. On review of systems he expresses concern about a history of premature ejaculation. What class of antidepressant may help | 496 | ||
7. Why have the selective serotonin reuptake inhibitors become first-line treatments for depression over the tricyclic antide | 496 | ||
8. Why might you want to avoid administering selective serotonin reuptake inhibitors and other antidepressants to this patien | 496 | ||
9. What class of antidepressant was this man likely started on if he experienced symptoms of dry mouth, blurred vision, const | 496 | ||
10. Assume that this patient responded well to some form of antidepressant therapy but then presented to the emergency room 3 | 496 | ||
11. If this man is addicted to red wine with cheese, what class of antidepressant should be avoided and why? | 496 | ||
12. How do monoamine oxidase inhibitors work and what are the two classes of monoamine oxidase inhibitors? | 497 | ||
13. What is the main danger of prescribing both a selective serotonin reuptake inhibitor and a monoamine oxidase inhibitor? | 497 | ||
14. If this patient is suffering from depression and is additionally a smoker who is trying to quit, which drug might be effe | 497 | ||
15. If this man experienced much milder symptoms of depression for longer than 2years, what would be his probable diagnosis? | 497 | ||
16. How might your diagnosis change if this man had been divorced 2months ago and his symptoms of depression were milder? | 497 | ||
17. If this man's wife died 1year ago and he was still experiencing these symptoms, what would his probable diagnosis be? | 498 | ||
Case16-4 | 498 | ||
1. Instead of speaking to his deceased brother, which he believes would be unacceptable, he begins to keep a diary, which he | 498 | ||
2. Why does this young man begin to wear his brother's clothing? What term is used to describe this type of activity? | 499 | ||
3. What term is used to describe him taking out his frustrations on his younger brother? | 499 | ||
4. What are the categories of defense mechanisms and what are some examples of each type? | 499 | ||
Case16-5 | 499 | ||
1. What are the five stages of grief this man will likely experience? | 499 | ||
2. What term is used to describe alleviating his frustration by abusing his wife? | 499 | ||
3. What defense mechanism would he be employing if he ignored the doctor's visit and went on with his life without acknowledg | 499 | ||
4. What term would be used to describe his behavior if while hospitalized he begins crying for his mother and demanding that | 500 | ||
5. Cover the left column of Table 16-1 and attempt to name the defense mechanisms described in the middle column. | 500 | ||
Case16-6 | 501 | ||
1. What are the considerations in the differential diagnosis? | 501 | ||
2. What is this patient's likely diagnosis? | 501 | ||
3. Using the DSM-IV criteria, under what axis would ADHD be listed? | 502 | ||
4. What class of drugs is the primary treatment for ADHD? | 502 | ||
5. What psychiatric symptoms might be evident in an individual following an overdose of amphetamines? | 502 | ||
Case16-7 | 502 | ||
1. What is the differential diagnosis? | 503 | ||
2. What are the criteria for Asperger's syndrome? | 503 | ||
3. What if the patient also repeated odd phrases and was unable to successfully engage in a conversation with his peers? | 503 | ||
4. How does autistic disorder differ from Asperger's syndrome? | 503 | ||
5. What is known about the etiology of autism spectrum disorders? | 503 | ||
6. What if the patient was not doing well academically and these behaviors and social impairments were manifested only at sch | 503 | ||
7. What should the workup include? | 503 | ||
8. What would be the diagnosis if the patient scored 70 or below on IQ testing? | 503 | ||
Case16-8 | 504 | ||
1. If the psychiatrist explains this boy's developmental maturation in terms of psychosexual development, what psychologist i | 504 | ||
2. Freud also discusses the id, ego, and superego. How do these concepts relate to this boy's problem? | 504 | ||
3. If the psychiatrist discusses the boy's development in terms of stages of cognitive development, what psychologist is he r | 504 | ||
4. If the psychiatrist explains this boy's development in terms of development of the ego, what psychologist is he referring | 505 | ||
Case16-9 | 506 | ||
1. What is the most likely diagnosis? | 506 | ||
2. What is the most likely etiology? | 506 | ||
3. What concern does this man's alcohol abuse pose to the medicine team? | 506 | ||
4. What are the expected symptoms of withdrawal and how are they managed? | 506 | ||
5. What is the mechanism by which the administration of benzodiazepines is able to control the delirium tremens? | 507 | ||
6. Another class of drugs act as agonists of the GABA receptor at a different site. What is the name of this group of drugs a | 507 | ||
7. How are substance abuse and dependence differentiated? | 507 | ||
Case16-10 | 508 | ||
1. Abuse involving what class of drugs should be expected in this man? | 508 | ||
2. Would you be surprised if this man's electrocardiogram revealed myocardial ischemia? | 508 | ||
3. What is the correct treatment for cocaine-induced coronary vasospasm? | 508 | ||
4. Why does this man have blood around his nostril? | 508 | ||
5. What are typical symptoms experienced by a person who is withdrawing from use of cocaine? | 508 | ||
6. A favorite on boards is to provide an emergency department presentation of somebody with a drug overdose and ask you to de | 508 | ||
Case16-11 | 510 | ||
1. Would this woman's current state be best described as dementia or delirium? | 510 | ||
2. What is the most likely cause of this woman's delirium? | 510 | ||
3. Distinguish dementia from delirium regarding onset, course, level of consciousness, and presence of delusions and hallucin | 510 | ||
Case16-12 | 511 | ||
1. What is the most likely diagnosis in this woman? | 511 | ||
2. If this woman subsequently developed a fear of leaving the house, what term should be used to describe this ``phobia&rdqu | 511 | ||
3. What are the considerations in the differential diagnosis for panic disorder? | 511 | ||
4. Why might the emergency department intern wish to check this woman's blood levels of thyroid hormone and urinary vanillylm | 512 | ||
5. How can this woman's panic disorder be treated? | 512 | ||
Case16-13 | 512 | ||
1. What is the most likely diagnosis in this girl? | 512 | ||
2. What are the requirements needed to make this diagnosis? | 512 | ||
3. Is this condition very disabling to patients and how is it best managed? | 513 | ||
Case16-14 | 513 | ||
1. What conditions are considered in the differential diagnosis for this patient? | 513 | ||
Case16-14 continued: | 513 | ||
2. What is this patient's likely diagnosis? | 513 | ||
3. Why does anorexia lead to amenorrhea? | 513 | ||
4. What other conditions are associated with anorexia nervosa? | 513 | ||
5. Compare the diagnoses of anorexia nervosa and bulimia nervosa. | 514 | ||
6. How should this patient be managed? | 514 | ||
Case16-15 | 515 | ||
1. What type of personality disorder is this man likely suffering from? | 515 | ||
Case16-16 | 515 | ||
Chapter 17: Neurology | 519 | ||
Basic Concepts | 519 | ||
1. What is a motor unit? Will most α motor neurons innervate a few or many muscle fibers in a large muscle such as the glut | 519 | ||
2. How do upper motor neurons differ from lower motor neurons? | 520 | ||
3. What is the primary function of the cerebellum in movement? | 521 | ||
4. Why do cerebellar lesions classically produce ipsilateral symptoms? | 521 | ||
5. What are the two ascending sensory pathways and what information does each convey? | 521 | ||
6. What are the two anatomic divisions of the dorsal columns, and from which anatomic structures do these respective division | 521 | ||
7. At what neuroanatomic locations do projections in the corticospinal tract, dorsal columns, and anterolateral system (spino | 521 | ||
8. Because you know where the major motor and sensory pathways cross over, identify and explain the neurologic deficits that | 522 | ||
9. Where will the motor and sensory deficit manifest (below the head) if there is a lesion of the internal capsule? | 523 | ||
Case17-1 | 524 | ||
1. How might we approach a case of suspected motor neuron disease? | 524 | ||
Case17-1 continued: | 524 | ||
2. What upper motor neuron signs are present in this patient? | 524 | ||
3. Why are the signs of hyperreflexia, spastic paralysis, and clonus seen with an upper motor neuron lesion? | 525 | ||
4. What lower motor neuron signs are present in this patient? | 525 | ||
Case17-1 continued: | 525 | ||
5. What process leads to the findings seen in this biopsy specimen stained with hematoxylin-eosin (H&E)? | 526 | ||
6. What would myosin adenosine triphosphatase (ATPase) staining of this specimen show? | 526 | ||
7. What is the most likely diagnosis? | 526 | ||
8. Why are the magnetic resonance imaging and cerebrospinal fluid findings notable? | 526 | ||
9. What are the principal pathologic findings in amyotrophic lateral sclerosis? | 526 | ||
10. What might you expect electromyography and nerve conduction studies to show in this patient? | 527 | ||
11. Is amyotrophic lateral sclerosis more commonly inherited or acquired? | 527 | ||
12. Why is amyotrophic lateral sclerosis often confused for syringomyelia and vice versa? | 527 | ||
Case17-2 | 528 | ||
1. With what actions is this tremor most likely to appear? | 528 | ||
2. Differentiate among resting tremor, intention tremor, and postural tremor. | 528 | ||
Case17-2 continued: | 528 | ||
3. In light of these signs, what is the most likely diagnosis for the tremor? | 528 | ||
4. How does a festinating gait differ from an ataxic gait? | 529 | ||
5. Why should we determine whether this patient is taking medications such as haloperidol or metoclopramide? | 529 | ||
6. What cerebral structures are affected in Parkinson's disease, and how does this play into the bradykinesia and akinesia ob | 529 | ||
Case17-2 continued: | 530 | ||
7. What medication did you start the patient on, and why is it, rather than dopamine, used to treat Parkinson's disease? | 530 | ||
8. Why is levodopa typically administered along with carbidopa? | 530 | ||
9. Drugs such as bromocriptine and pergolide are also used to treat Parkinson's disease. How do they exert their effects? | 530 | ||
10. What is the mechanism of action of selegiline, a drug used in treating Parkinson's disease? | 530 | ||
11. Why is it preferable to selectively inhibit monoamine oxidase B, rather than both monoamine oxidase A and monoamine oxida | 530 | ||
12. What is benztropine and why is it useful in Parkinson's disease? | 530 | ||
13. Which antiviral medication is also effective in treating Parkinson's disease? | 530 | ||
14. How does the drug MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) cause parkinsonism, and is this a reversible proces | 531 | ||
15. Why should you be suspicious of a diagnosis of Parkinson's disease in a patient being treated for schizophrenia? | 531 | ||
16. What would a pathologist look for to establish the diagnosis of Parkinson's disease in evaluation of the brain at autopsy | 531 | ||
Case17-3 | 531 | ||
1. What term describes the patient's movements, and what conditions may cause these movements? | 531 | ||
2. Why might medications such as haloperidol and l-dopa cause chorea? | 532 | ||
Chapter 18: Ophthalmology | 568 | ||
Basic concepts | 568 | ||
1. Describe the course of visual information arriving from the left and right visual fields. | 568 | ||
2. What visual field defect results from midline sectioning of the optic chiasm? Explain. | 569 | ||
3. What visual field deficit will occur with sectioning of the left optic tract and why? | 570 | ||
4. What visual field deficit is likely with a tumor in the right temporal lobe? | 570 | ||
5. A physician shines a light into a patient's right eye and notes bilateral constriction of both pupils (normal response). D | 571 | ||
6. If there is a lesion in the left optic nerve, what would be the pupillary response if a light is shone into the right eye | 571 | ||
7. What will the pupillary response be to shining a light in either eye if there is a lesion in the left oculomotor nerve? | 572 | ||
8. What is an Argyll Robertson pupil? | 572 | ||
9. If the oculomotor nerve is paralyzed on one side, why is the eyeball on that side rotated laterally and inferiorly (``dow | 572 | ||
10. Describe the function of the medial longitudinal fasciculus. | 573 | ||
11. What is pathologic nystagmus? | 573 | ||
Case18-1 | 574 | ||
1. What is the most likely diagnosis? | 574 | ||
2. What is the difference between open-angle glaucoma and closed-angle glaucoma? | 574 | ||
3. What is the mechanism by which beta blockers reduce intraocular pressure in glaucoma? | 575 | ||
4. What is the mechanism of action by which topical and oral carbonic anhydrase agents (e.g., acetazolamide) could be used to | 575 | ||
Related Questions | 575 | ||
5. Why are cholinomimetics like pilocarpine and carbachol useful for closed-angle glaucoma? | 575 | ||
6. Why should epinephrine be avoided in closed-angle glaucoma? | 575 | ||
Case18-2 | 576 | ||
1. What is the most likely diagnosis? | 576 | ||
2. What is the difference between ``dry´´ and ``wet´´ age-related macular degeneration? | 576 | ||
3. Where is the macula and what is its function? | 576 | ||
4. What is the mechanism of action for the intravitreal injection of ranibizumab that will be used to treat this man's age-re | 576 | ||
5. What simple diagnostic test can be carried out to detect age-related macular degeneration? | 576 | ||
Chapter 19: Rheumatology | 577 | ||
Basic concepts | 577 | ||
1. What is a ``diarthrodial´´ joint? | 577 | ||
2. What are the components of a diarthrodial joint and which sites within a diarthrodial joint are vulnerable to disease? | 577 | ||
3. What are synarthrodial and amphiarthrodial joints? | 577 | ||
Case19-1 | 579 | ||
1. What is the differential diagnosis? | 579 | ||
Case19-1 continued: | 579 | ||
2. What is the likely diagnosis? | 579 | ||
3. Is the pathogenesis of this condition primarily related to degeneration of bone, cartilage, or synovial membrane? | 580 | ||
4. What is the anatomic source of the joint pain in osteoarthritis? | 580 | ||
5. What are some risk factors associated with developing osteoarthritis? | 580 | ||
6. Would you expect the erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) to be elevated in this patient? | 581 | ||
7. How do the findings on x-ray studies generally differ between osteoarthritis and rheumatoid arthritis? | 581 | ||
8. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors are both possible treatments for this patient. What i | 582 | ||
9. What is the principal therapeutic advantage of the cyclooxygenase-2 inhibitors? What can be given to this patient with a n | 582 | ||
10. Why are cyclooxygenase-2 inhibitors considered dangerous in some patients? | 582 | ||
11. Is acetaminophen a reasonable option for treating joint pain in this patient? | 582 | ||
12. What sort of analgesic would you prescribe for a patient with preexisting renal disease? Or liver disease? Or pregnancy? | 582 | ||
13. Quick review: Look only at the left column in Table19-1 and try to list the class of drug, mechanism of action, and majo | 583 | ||
Case19-2 | 583 | ||
1. What is the differential diagnosis? | 584 | ||
Case19-2 continued: | 584 | ||
2. What is the diagnosis? | 584 | ||
3. What are the criteria for the diagnosis of rheumatoid arthritis? | 584 | ||
4. What sort of damage occurs in the joints of patients with rheumatoid arthritis? | 585 | ||
5. What is the significance of rheumatoid factor in this disease? | 585 | ||
6. What is the epidemiology of rheumatoid arthritis? | 585 | ||
7. What is the typical treatment for rheumatoid arthritis? | 585 | ||
8. What would be learned from aspiration of this patient's knee? | 585 | ||
Case19-2 continued: | 586 | ||
9. What are the characteristic deformities in the hands in advanced rheumatoid arthritis? | 586 | ||
10. What are the extra-articular manifestations of rheumatoid arthritis? | 587 | ||
Case19-3 | 587 | ||
1. What is your differential diagnosis? | 587 | ||
2. How can crystal and septic arthritis be differentiated? | 587 | ||
Case19-3 continued: | 588 | ||
3. What is the likely diagnosis? | 588 | ||
4. What is the pathophysiology of this condition? | 588 | ||
5. Do most people with hyperuricemia develop gout? | 588 | ||
6. What is Lesch-Nyhan syndrome and why might it predispose to gout? | 588 | ||
7. Are there any complications of gout besides the monoarticular inflammatory arthritis? | 589 | ||
8. Are there any medications that can precipitate attacks of gout? | 589 | ||
Case19-3 continued: | 589 | ||
9. What other treatment options exist for an acute gout attack? | 589 | ||
10. Who needs chronic treatment for gout, and what does this treatment consist of? | 590 | ||
11. What is pseudogout? | 590 | ||
One Last Crystal | 590 | ||
12. What is going on here? | 590 | ||
Case19-4 | 591 | ||
1. What is your differential diagnosis for diffuse musculoskeletal pain and fatigue? | 591 | ||
Case19-4 continued: | 591 | ||
2. What is the likely diagnosis? | 592 | ||
3. What causes fibromyalgia? | 592 | ||
4. Are steroids indicated? | 592 | ||
5. Who is prone to developing fibromyalgia? | 592 | ||
Case19-5 | 593 | ||
1. What is the diagnosis in this patient? | 593 | ||
2. How is this condition treated? | 593 | ||
3. What else should be looked for in patients with suspected polymyalgia rheumatica? | 593 | ||
Case19-6 | 594 | ||
1. What is your differential diagnosis? | 594 | ||
Case19-6 continued: | 594 | ||
2. What is the Phalen sign? What is the Tinel sign? | 594 | ||
3. What is your diagnosis? | 594 | ||
4. What causes carpal tunnel syndrome? | 594 | ||
5. What structures pass through the carpal tunnel? | 595 | ||
6. What does the median nerve innervate in the hand? | 595 | ||
7. What are treatment options for carpal tunnel syndrome? | 595 | ||
Case19-7.1 | 596 | ||
1. What is the diagnosis? | 596 | ||
2. What is the bamboo spine? | 597 | ||
Case19-7.2 | 597 | ||
1. What is the likely diagnosis? | 597 | ||
2. What triggers this condition? | 597 | ||
Case19-7.3 | 597 | ||
1. What is the diagnosis here? | 597 | ||
2. What joints are affected by psoriatic arthritis? | 597 | ||
Case19-8 | 599 | ||
1. What do you think is going on here? | 599 | ||
Case19-8 continued: | 599 | ||
2. What is your diagnosis? | 599 | ||
3. What is the pathogenesis of scleroderma? | 600 | ||
4. Which sort of scleroderma does this patient have? | 600 | ||
5. What is the reason for the reflux? | 600 | ||
CASE19-8 continued: | 600 | ||
6. What are the renal manifestations of diffuse scleroderma? | 600 | ||
7. What is the current leading cause of death for these patients? | 601 | ||
8. What is the CREST syndrome? | 601 | ||
9. What is localized scleroderma? | 601 | ||
10. How is scleroderma treated? | 601 | ||
11. Quick review: Cover columns 2, 3, and 4 in Table19-2 and describe the various characteristics of diffuse, limited, and l | 602 | ||
Case19-9 | 603 | ||
1. What is the likely diagnosis in this patient? | 603 | ||
2. How can a diagnosis of discoid lupus be confirmed? | 603 | ||
3. What treatment options exist for discoid lupus? | 603 | ||
Case19-9 continued: | 603 | ||
4. What is the likely diagnosis? | 604 | ||
5. What is the pathogenesis of systemic lupus erythematosus? | 604 | ||
6. What causes lupus? | 604 | ||
7. What are the criteria for diagnosing systemic lupus erythematosus? | 604 | ||
8. What are ``antinuclear antibodies,´´ and are they sensitive or specific for systemic lupus erythematosus? | 604 | ||
9. What is causing this patient's dry mouth and dry eyes? | 604 | ||
10. What is the reason for the proteinuria? | 605 | ||
11. What is the reason for this woman's anemia? | 605 | ||
12. Why did this patient have a positive Venereal Disease Research Laboratory (VDRL) test? | 605 | ||
13. What are the treatment options for systemic lupus erythematosus? | 605 | ||
14. What medications are responsible for drug-induced lupus? | 605 | ||
15. Quick review: Cover the right column in Table19-3 and give the primary disease(s) associated with the autoantibodies lis | 606 | ||
Case19-10 | 607 | ||
1. What is your differential diagnosis? | 607 | ||
Case19-10 continued: | 607 | ||
2. What is the diagnosis? | 608 | ||
3. What causes this disease? | 608 | ||
4. What is the treatment? | 608 | ||
5. What are the other ``idiopathic inflammatory myopathies´´? | 608 | ||
6. What disease that is transmitted by pork can cause similar muscular symptoms? | 608 | ||
Case19-11 | 609 | ||
1. What is your differential diagnosis? | 609 | ||
Case19-11 continued: | 609 | ||
2. What is the most likely diagnosis? | 609 | ||
3. Is this condition more commonly acquired or inherited? | 609 | ||
4. What is the function of dystrophin? | 610 | ||
5. How do the manifestations of Becker's muscular dystrophy differ? | 610 | ||
6. Why does this boy have such large calf muscles on examination? What term is used to describe this finding in Duchenne's mu | 610 | ||
7. How is a Gowers´ sign elicited on examination and what does it indicate? | 611 | ||
A Few More Muscular Dystrophies | 611 | ||
8. What diagnosis might you suspect? | 611 | ||
9. What is the mechanism of inheritance of myotonic dystrophy? | 611 | ||
10. What is the diagnosis? | 612 | ||
Case19-12 | 612 | ||
Case19-12.1 | 612 | ||
1. What is your diagnosis? | 612 | ||
2. What causes the bones to be dense and thick in this patient? | 613 | ||
3. Why might you see anemia in osteopetrosis and why is it referred to as a myelophthisic anemia? | 613 | ||
4. Should you observe any laboratory value abnormalities in a patient who has osteopetrosis? | 613 | ||
Case19-12.2 | 614 | ||
5. Infection with what organisms should be suspected? | 614 | ||
Case19-12.3 | 614 | ||
6. What most likely explains this? | 614 | ||
Case19-12.4 | 614 | ||
7. What is your diagnosis and what is the etiology of this condition? | 614 | ||
8. Quick review: Cover the right column in Table19-4 and list the pathophysiologic abnormality associated with each of the | 615 | ||
Chapter 20: Vasculitides | 618 | ||
Basic Concepts | 618 | ||
1. What are the vasculitides and how do they typically present clinically? | 618 | ||
2. Along with constitutional complaints, what clinical signs and patterns of organ involvement suggest a vasculitic syndrome? | 618 | ||
3. How are the vasculitides classified? | 619 | ||
4. Cover the right column in Table20-1 and attempt to describe the ``classic presentation´´ for each of the liste | 619 | ||
Case20-1 | 620 | ||
1. What are the main considerations in your differential diagnosis? | 620 | ||
Case20-1 continued: | 620 | ||
2. What is the likely diagnosis? | 620 | ||
3. What does the elevated erythrocyte sedimentation rate imply? | 620 | ||
4. In temporal arteritis, what events lead to inflammation of the artery? | 621 | ||
Case20-1 continued: | 621 | ||
5. Why might it still make sense to treat this patient? | 621 | ||
6. What severe complication of this disorder may be avoided by initiating immunosuppressive therapy as soon as possible? | 621 | ||
7. What other symptomatic manifestations may be expected as a result of arterial inflammation in patients with giant cell art | 621 | ||
8. How can response to corticosteroids be monitored? | 621 | ||
9. What other disease is giant cell arteritis associated with? | 622 | ||
Case20-2 | 622 | ||
1. What are the considerations in your differential diagnosis? | 622 | ||
Case20-2 continued: | 623 | ||
2. What is your diagnosis? | 623 | ||
3. What is the major concern in patients with this disease who do not receive adequate therapy? | 623 | ||
4. What is the pathogenesis of Kawasaki disease? | 624 | ||
5. How is this disease treated? | 624 | ||
6. Describe the epidemiology of this disease. | 624 | ||
Case20-3 | 625 | ||
1. What is your differential diagnosis? | 625 | ||
Case20-3 continued: | 625 | ||
2. What is the likely diagnosis? | 625 | ||
3. What causes disease manifestations? | 625 | ||
4. What is the usual progression of symptoms in this disease? What other organ systems will likely become involved? | 625 | ||
5. How is Wegener's granulomatosis treated? | 626 | ||
Case20-4 | 626 | ||
1. What is the diagnosis? | 626 | ||
2. What is the significance of the positive hepatitis B surface antigen in this patient? | 627 | ||
Case 20-3 continued: | 627 | ||
3. What are the dermatologic manifestations of polyarteritis nodosa? | 628 | ||
4. How can the diagnosis of polyarteritis nodosa be confirmed? | 628 | ||
Case20-4 continued: | 628 | ||
5. Given the high-dose steroids, what prophylaxis needs to be considered? | 628 | ||
Case20-5 | 629 | ||
1. What is the likely diagnosis in this patient? | 629 | ||
2. What is Takayasu's arteritis? | 629 | ||
3. What makes this patient different from the typical presentation of Takayasu's arteritis? | 629 | ||
4. Ischemic complication due to vascular involvement of the arch of the aorta and its major branches led to this patient's sy | 630 | ||
5. How is the diagnosis made? | 630 | ||
6. How is this disease treated? | 630 | ||
Chapter 21: Bacterial Diseases | 631 | ||
Basic Concepts | 631 | ||
1. What makes an organism gram-positive or gram-negative? | 631 | ||
2. Why are gram-negative infections more likely to produce bacterial sepsis? | 631 | ||
3. Describe the mechanism by which lipid A causes toxicity? | 632 | ||
4. What are exotoxins? | 632 | ||
5. What is a capsule and what purpose does it serve? | 633 | ||
6. What sort of individuals are susceptible to infection by encapsulated bacteria? | 633 | ||
7. Identify the Gram stain and the morphology of the organisms in Table 21-1. | 634 | ||
8. Cover the two columns on the right in Tables 21-2 through 21-9 to test your knowledge of the properties of the clinically | 635 | ||
Basic Concepts in Antibacterial Pharmacology | 637 | ||
1. What are the β-lactam antibiotics and what is their mechanism of action? | 637 | ||
2. Why are clavulanic acid and sulbactam added to some penicillins? | 639 | ||
3. What is the antibacterial spectrum of the various subclasses of penicillins and cephalosporins (Table 21-10)? | 639 | ||
4. What is the antibacterial spectrum of the fluoroquinolones and what is their mechanism of action? | 641 | ||
5. What is the spectrum and mechanism of action of the macrolides? | 643 | ||
6. What is special about the tetracyclines? | 643 | ||
7. What are the mechanism of action and spectrum of the aminoglycosides? | 643 | ||
8. How does chloramphenicol work and why is it not used more often? | 643 | ||
9. Why is trimethoprim commonly given in combination with sulfamethoxazole, as TMP-SMX? | 643 | ||
10. Cover the two columns on the right of Table 21-11 and describe the mechanism of action and mechanism of bacterial resista | 643 | ||
11. Cover the right column in Table 21-12 and describe the adverse effects for each of the antimicrobial agents listed in the | 644 | ||
Case21-1 | 645 | ||
1. What is the most likely diagnosis? | 646 | ||
2. What defense mechanisms prevent pneumonia in the healthy individual? | 646 | ||
3. Why might a patient in the intensive care unit who is intubated be at increased risk for developing pneumonia? | 646 | ||
4. Why is it important to distinguish between community-acquired and nosocomial pneumonia? | 646 | ||
5. What is atypical (``walking´´) pneumonia, and is the patient in this case more likely have a typical or an atypical | 646 | ||
Case21-1 continued: | 647 | ||
6. What is the diagnosis? | 648 | ||
7. How should this patient be treated pharmacologically? | 648 | ||
8. Use Table 21-13 to quiz yourself on the most common causes of pneumonia in different age groups. | 648 | ||
9. Use Table 21-14 to quiz yourself on the important characteristics of the organisms that are known to cause pneumonias. | 648 | ||
Case21-2 | 650 | ||
1. What is the most likely diagnosis? | 650 | ||
2. What other types of diarrhea can be caused by Escherichia coli? | 650 | ||
3. What is the difference between osmotic and secretory diarrhea? Name a cause for each type. | 651 | ||
4. What predisposes to Clostridium difficile colitis and what sort of diarrhea does this cause? | 652 | ||
5. How is diarrhea treated? | 652 | ||
Case21-3 | 654 | ||
1. What is the most likely diagnosis? | 654 | ||
2. What are the major risk factors for developing endocarditis? | 656 | ||
3. What are the clinical signs of bacterial endocarditis? | 656 | ||
4. What are the clinical signs of rheumatic fever? | 656 | ||
5. Which bacteria are most commonly associated with bacterial endocarditis? | 658 | ||
6. What drugs could be used to treat this patient? | 658 | ||
7. How does bacterial endocarditis differ from Libman-Sacks endocarditis? | 658 | ||
Case21-4 | 659 | ||
1. What is the likely diagnosis? | 659 | ||
2. Based on this man's presentation, in which ``stage´´ of syphilitic infection is he most likely to be? | 659 | ||
3. What stage of syphilis would you suspect in a patient with a diffuse maculopapular rash? | 659 | ||
Case21-4 continued: | 660 | ||
4. What is the likely diagnosis? | 660 | ||
5. Use Table 21-21 to quiz yourself on the three stages of syphilitic infection. | 660 | ||
6. What diagnostic tests could be done to definitively diagnose syphilis in this man? | 660 | ||
7. How would you treat this patient? | 660 | ||
8. Later that night, the patient calls you at home with serious concerns about a reaction to penicillin. He states that sever | 662 | ||
Case21-5 | 662 | ||
1. What is the most likely diagnosis? | 663 | ||
2. What stage of Lyme disease would you suspect in this child? | 663 | ||
3. How would your diagnosis change if this patient presented with a similar history but had complaints of various painful swo | 663 | ||
4. If this patient does not receive appropriate treatment, what is the likelihood that the infection will progress to stage 3 | 664 | ||
5. What is the treatment for Lyme disease? Name a preventive measure that can be taken. | 664 | ||
6. Describe the Ixodes life cycle. | 664 | ||
Case21-6 | 665 | ||
1. What is the presumptive diagnosis? | 665 | ||
2. How is this disease primarily transmitted? | 665 | ||
3. Why is the acid-fast stain required to visualize this bacterium? | 666 | ||
4. Does this patient most likely have primary tuberculosis, latent tuberculosis, or recrudescent (secondary) tuberculosis? | 666 | ||
5. What are the first-line drugs for treating tuberculosis and why are they always used in combination? | 667 | ||
6. If this patient is treated with isoniazid as part of his regimen, why should he also receive supplemental pyridoxine (vita | 667 | ||
7. If this patient is treated with rifampin as part of his regimen, why may he need larger doses of opioid analgesics for pai | 667 | ||
8. Three weeks after starting a therapeutic regimen with rifampin and isoniazid the patient complains of orange urine. What i | 667 | ||
9. If this patient begins complaining of vision problems, what would you suspect is the cause? | 667 | ||
10. Why is the standard treatment regimen that this patient will be put on so prolonged? | 667 | ||
Related Questions | 667 | ||
11. Is cell-mediated immunity or humoral immunity more important for fighting tuberculosis? Why? | 667 | ||
12. How does the purified protein derivative skin (Mantoux) test work? | 667 | ||
13. Why is reactivation tuberculosis more likely to occur in the apical lungs rather than in the lower lobes? | 668 | ||
14. What type of necrosis is associated with granulomatous cell death in tuberculosis? | 668 | ||
15. What type of secondary infection can be seen in pulmonary cavitation such as that associated with tuberculosis? | 668 | ||
16. How can tuberculosis cause a urinalysis to show microscopic pyuria and hematuria (with red blood cell casts) in the face | 668 | ||
17. Why might Pott's disease be suspected in a patient with tuberculosis who has new-onset back pain but denies any trauma th | 668 | ||
Case21-7 | 668 | ||
1. What is the most likely diagnosis? | 669 | ||
2. What is unique about the chlamydial cell wall? | 669 | ||
3. When a sample of infected tissue is stained with Giemsa, where will the chlamydial bacteria be seen? | 669 | ||
4. How is pelvic inflammatory disease transmitted and why can it lead to pelvic discomfort, vaginal discharge, and vaginal bl | 669 | ||
5. What are the two organisms that could most likely cause her symptoms? | 669 | ||
6. What test would you do to differentiate between these two organisms and why? | 669 | ||
7. How are Chlamydia trachomatis and Neisseria gonorrhoeae transmitted? | 669 | ||
Case21-7 continued: | 669 | ||
8. What should be prescribed as a treatment for your patient? | 669 | ||
9. If the patient's current and past partners do not have any symptoms, should they also be considered for treatment? | 669 | ||
10. Why is the fact that the patient was using an intrauterine device significant in this case? | 670 | ||
11. What are other risk factors for the development of pelvic inflammatory disease? | 670 | ||
12. If this patient was not using any birth control and had been trying to become pregnant, what other concerns would you nee | 670 | ||
13. What is Reiter's syndrome? | 670 | ||
14. Describe the unique life cycle of a chlamydial infection. | 670 | ||
15. What are the serotypes of Chlamydia trachomatis that can cause pelvic inflammatory disease? | 671 | ||
16. What are the other species of Chlamydia and what diseases do they cause? | 671 | ||
Case21-8 | 671 | ||
1. What is the most likely diagnosis? | 672 | ||
2. What is the ``classic triad´´ of symptoms associated with meningitis? | 672 | ||
3. What are the Brudzinski and Kernig signs? | 672 | ||
4. What are the possible causes for meningitis? What tests can be done to make the diagnosis of meningitis and identify the c | 672 | ||
5. What are the most common causes of meningitis by age group? Use Table 21-27 to quiz yourself. | 672 | ||
6. Haemophilus influenzae used to be the most common cause of meningitis in newborns but is now only rarely seen in this age | 672 | ||
7. When would be an appropriate time to initiate antibiotic therapy in this patient and what antimicrobial agent could be use | 673 | ||
8. A Gram stain of the cerebrospinal fluid shows gram-negative cocci in pairs. What is the most likely cause of the meningiti | 673 | ||
9. In a patient with human immunodeficiency virus (HIV), what infective agents may be more likely to cause meningitis than in | 673 | ||
Chapter 22: Viral, Parasitic, and Fungal Diseases | 674 | ||
Basic concepts in virology | 674 | ||
1. What structural components are used to categorize viruses? | 674 | ||
2. Name the disease associated with each DNA virus listed in Table 22-1. | 676 | ||
3. Cover the right-hand column in Table 22-2, and using the clinical description given, name the most likely virus. | 677 | ||
Basic concepts in parasitology | 678 | ||
1. What are protozoa? | 678 | ||
2. What is the difference between cestodes, nematodes, and trematodes? | 679 | ||
3. Cover the left column in Table 22-4, and from the description of the infection at the right, name the helminth that causes | 679 | ||
Basic concepts in mycology | 680 | ||
1. What are the two morphologic types of pathogenic fungi? | 680 | ||
2. What is meant by the term dimorphic fungi? | 680 | ||
3. How do the antifungal ``-azole´´ agents work? | 681 | ||
4. What is the mechanism of action for amphotericin B and nystatin? | 681 | ||
5. Cover the right-hand column in Table 22-5 and determine the most likely fungal organism based on the clinical description | 681 | ||
Case22-1 | 682 | ||
1. With this initial history, what is your differential diagnosis? | 682 | ||
Chapter 23: Pharmacology and Toxicology | 693 | ||
Basic Concepts | 693 | ||
1. How does the route by which a drug is administered affect its metabolism? | 693 | ||
2. What does the Henderson-Hasselbalch equation mean? | 694 | ||
3. What is the difference between zero-order kinetics and first-order kinetics? | 694 | ||
4. What is half-life? | 695 | ||
5. What is the difference between loading dose and maintenance dose and how is this affected by liver and renal disease? | 695 | ||
6. What is therapeutic index? | 695 | ||
7. What are the differences between competitive and noncompetitive inhibitors? | 695 | ||
Case23-1 | 696 | ||
1. Given the preceding clinical picture, what is the most likely explanation for this patient's presentation? | 696 | ||
2. What are the pharmacotherapeutic actions of aspirin and other nonsteroidal anti-inflammatory drugs? | 696 | ||
3. What is the mechanism of action of NSAIDs? | 697 | ||
4. What are some side effects of NSAIDs, and what alternative medications exist that circumvent these side effects? | 697 | ||
5. If given the choice of aspirin or acetaminophen, which would you administer to a child with a fever. | 697 | ||
Case23-2 | 698 | ||
1. On the basis of the preceding information, what can be the cause of this patient's presentation? | 698 | ||
2. What is the mechanism of action of opioids? | 698 | ||
3. List a few members of the opioid family. | 699 | ||
4. What are some signs/symptoms of opioid intoxication? Is it life-threatening? | 699 | ||
5. How can an opioid overdose be reversed? | 699 | ||
6. What is the difference between naloxone and naltrexone? | 699 | ||
7. What role can methadone play in treating opioid dependence? | 699 | ||
8. What are signs/symptoms of opioid withdrawal? | 699 | ||
Case23-3 | 700 | ||
1. Given this clinical picture, what is the most likely explanation for this patient's presentation? | 700 | ||
2. What is the mechanism of action of cocaine? | 700 | ||
3. The net effects of cocaine on the body can mimic those of which other illicit drug? | 700 | ||
4. What is the explanation for development of tolerance to cocaine use? | 700 | ||
5. Aside from tolerance and dependence, what are some other adverse effects of cocaine? | 700 | ||
Amphetamines | 701 | ||
6. How does the mechanism of action of amphetamines differ from that of cocaine? | 701 | ||
7. What are some adverse effects of amphetamines? | 701 | ||
Lysergic Acid Diethylamide (LSD) | 701 | ||
8. What is the mechanism of action of LSD and its effects on the body? | 701 | ||
Phencyclidine (PCP) | 701 | ||
9. What is the mechanism of action of phencyclidine and its resultant effects on the body? | 701 | ||
Tetrahydrocannabinol (THC) | 701 | ||
10. What is the mechanism of action of tetrahydrocannabinol and its resultant effects on the body? | 701 | ||
Case23-4 | 702 | ||
1. Based on this presentation, what is the likely culprit? | 702 | ||
2. What is the mechanism of action of digitalis? | 702 | ||
3. What are clinical indications for using glycosides? | 703 | ||
4. What are some adverse effects of glycosides? | 703 | ||
Case23-5 | 704 | ||
1. In general terms, how does a caustic agent damage tissue? | 704 | ||
2. How do alkaline agents damage cells, tissues, and organs? | 704 | ||
3. How do acidic agents damage cells, tissues, and organs? | 704 | ||
4. If you encountered the preceding patient in the emergency department, what are the next few steps that would need to be ad | 704 | ||
Case23-6 | 705 | ||
1. What is likely causing this patient's symptoms? | 705 | ||
2. What is the mechanism of action of calcium channel blockers? | 705 | ||
3. What are the different types of calcium channel blockers? | 705 | ||
4. What are some general side effects of calcium channel blockers? | 707 | ||
Case23-7 | 707 | ||
1. Given the preceding presentation, which types of items are at the top of the differential diagnosis and would be worth exp | 707 | ||
2. What is the mechanism of action of benzodiazepines? | 708 | ||
3. What are a few clinical indications for using benzodiazepines? | 708 | ||
4. What are some common adverse effects of benzodiazepines? | 708 | ||
5. What are symptoms of benzodiazepine intoxication and withdrawal? | 709 | ||
Case23-8 | 709 | ||
1. Given his recent uncomplicated hospital course and his benign past medical history, what condition is this patient likely | 709 | ||
2. What are the symptoms of acute alcohol toxicity and how can these effects be explained at the molecular level? | 710 | ||
3. What are symptoms of chronic alcohol abuse? | 710 | ||
4. What is the relationship between alcohol and benzodiazepines in terms of their effect on the brain? | 710 | ||
5. How is alcohol metabolized in the body? | 710 | ||
Case23-9 | 711 | ||
1. Given this presentation, which other laboratory values would prove informative? Should this patient be treated based on th | 711 | ||
2. Is acetaminophen considered a nonsteroidal anti-inflammatory drug? | 711 | ||
3. What is the mechanism of action of acetaminophen? | 712 | ||
Case23-10 | 712 | ||
1. Given this patient's presentation, which group of medications is the likely culprit? | 712 | ||
2. In general terms, how is the nervous system organized? | 713 | ||
3. Which neurotransmitter can be said to be pivotal to the function of the entire motor nervous system? | 713 | ||
4. Is there a way to selectively affect the parasympathetic nervous system? | 714 | ||
5. What is one way to reduce the side effects of a drug that stimulates both nicotinic and muscarinic receptors? | 714 | ||
6. Are there nicotinic receptor blockers that are selective for the autonomic nervous system or somatic nervous system rather | 714 | ||
7. How can a cholinergic drug help diagnose myasthenia gravis? | 715 | ||
Case23-11 | 716 | ||
1. Given this clinical picture, what scenario best explains this patient's presentation? | 716 | ||
2. What is the mechanism of action of barbiturates? | 716 | ||
3. What are some common indications for using barbiturates? | 716 | ||
4. What are some common adverse effects of barbiturates? | 717 | ||
Case23-12 | 717 | ||
1. Given this presentation, to which group of antihypertensives does the likely culprit belong? | 718 | ||
2. In the sympathetic nervous system, what are the two types of neurotransmitters and the two main adrenergic receptors? | 718 | ||
3. Describe α-receptors in terms of their distribution in the body and a few of their agonists/antagonists. | 718 | ||
4. Describe β-receptors in terms of their distribution in the body and a few of their agonists/antagonists. | 719 | ||
Case23-13 | 720 | ||
1. What is the likely cause of this man's symptoms? | 720 | ||
2. How does organophosphate poisoning result in this patient's symptoms? | 720 | ||
3. What is the treatment for organophosphate poisoning? | 721 | ||
4. Atropine administration alone relieves which of the DUMBBELSS symptoms? | 721 | ||
Chapter 24: Behavioral sciences | 722 | ||
Case24-1 | 722 | ||
1. What are the considerations in the differential diagnosis? | 722 | ||
2. In addition to a diagnosis of adjustment disorder with depressed mood, what sleep-related disorder likely explains most of | 723 | ||
3. What treatment can be employed to allow this man to sleep at night? | 723 | ||
Case24-2 | 723 | ||
1. What are the considerations in the differential diagnosis? | 723 | ||
2. What is the likely diagnosis and what would be the expected electroencephalographic findings? | 724 | ||
3. Which treatment is available for patients with narcolepsy? | 724 | ||
4. What are the stages of sleep and what happens physiologically in these stages? | 724 | ||
5. In Table24-1, cover the columns to the right, and for each stage of sleep listed in the left column, name the EEG appear | 724 | ||
6. How do nightmares differ from night terrors? | 725 | ||
7. An 82-year-old woman complains that her sleep patterns have changed as she has aged. What changes in sleep are typical as | 725 | ||
8. This woman had been given a benzodiazepine to assist her sleep, which improved for a while, but now she complains of poor | 725 | ||
9. How do benzodiazepines manifest their pharmacologic effect? | 725 | ||
10. Why would this be another reason benzodiazepines should be avoided in the elderly population? | 725 | ||
11. There are now a number of drugs other than benzodiazopines that also act on the γ-aminobutyric acid benzodiazepine recep | 726 | ||
12. When evaluating a person for sleep problems, perhaps the first and most important step is to make sure that the patient h | 726 | ||
Case24-3 | 726 | ||
1. What should the physician do? | 726 | ||
2. What are advance directives? | 726 | ||
3. How is competence (decision-making capacity) defined? | 727 | ||
4. What is substituted judgment? | 727 | ||
Case24-4 | 727 | ||
1. What should you do? | 727 | ||
2. What are the rules regarding parental consent for minors? | 727 | ||
Case24-5 | 728 | ||
1. What do you do? | 728 | ||
2. Is it a good idea for you to be honest and tell her that you cannot have a relationship with her while she is your patient | 728 | ||
Case24-6 | 729 | ||
1. What do you do? | 729 | ||
2. Under what other conditions is it acceptable to violate patient confidentiality? | 729 | ||
Case24-7 | 729 | ||
1. What is the differential diagnosis for this patient's sexual dysfunction? | 729 | ||
2. What changes occur in the elderly with regard to sexual health? | 730 | ||
Case24-8 | 730 | ||
1. What should you do? | 730 | ||
Case24-9 | 730 | ||
1. What do you do? | 731 | ||
2. What is the CAGE questionnaire? | 731 | ||
Case24-10 | 731 | ||
1. Is this child developing normally? | 731 | ||
2. What should you tell this concerned parent? | 731 | ||
Case24-11 | 733 | ||
1. How should you handle this situation? | 733 | ||
2. How can compliance be increased in the future? | 733 | ||
Case24-12 | 734 | ||
1. How should you handle this situation with the patient's wife? | 734 | ||
2. What should you say to the patient when you walk into the room? | 734 | ||
Case24-13 | 734 | ||
1. What is the most likely diagnosis? | 734 | ||
2. What are the most common symptoms of restless legs syndrome? | 735 | ||
3. How is restless legs syndrome treated? | 735 | ||
Chapter 25: Biostatistics | 736 | ||
Basic concepts | 736 | ||
Test Characteristics | 736 | ||
1. What does the sensitivity of a diagnostic test measure? | 736 | ||
2. What does the specificity of a diagnostic test measure? | 737 | ||
3. Quick terminology review: Cover the right column in Table25-2 and define each of the terms in the left column. | 737 | ||
4. How does the sensitivity of a test relate to its specificity? | 737 | ||
5. What information is given by the relative risk? | 738 | ||
6. What information is given by the odds ratio? | 738 | ||
7. What is the difference between probability and odds and how are they measured? | 738 | ||
8. What is the positive predictive value? negative predictive value? | 739 | ||
9. What is the positive likelihood ratio? | 739 | ||
10. How is the positive likelihood ratio used to calculate the positive predictive value? | 739 | ||
11. What is meant by the reliability of a test? | 740 | ||
12. What is meant by the validity of a test? | 740 | ||
13. In statistical analyses of differences between groups, a P value is often included to reflect how significant the differe | 740 | ||
14. What are the differences between type I and type II error? How is power related to type II error? | 740 | ||
15. What are some determinants that can be used to evaluate the existence of a causal relationship between two variables? | 741 | ||
16. What is the difference between prevalence and incidence? | 741 | ||
17. How do the incidence and duration of a disease affect its prevalence? | 741 | ||
Measures of Spread | 741 | ||
18. The following sample distribution pattern lists the ages of 11 patients seen by a physician on a given day: | 741 | ||
19. What does the standard deviation of a population represent? | 743 | ||
Study Designs | 744 | ||
20. What is meant by the term ``bias´´ and which study design best eliminates bias? | 744 | ||
Case25-1 | 744 | ||
1. What sort of study design was this? | 744 | ||
2. How does a retrospective case-control study differ in design from a retrospective cohort study? | 744 | ||
3. What are the strengths of a case-control study? | 746 | ||
4. What are the limitations of a case-control study? | 746 | ||
5. What ratio can be used to compare event rates in a case-control study? | 748 | ||
6. How is the odds ratio calculated? | 748 | ||
Case25-2 | 749 | ||
1. What does the expression ``13010mm Hg´´ mean with respect to the distribution of blood pressure in this sam | 749 | ||
2. What does it mean when the blood pressure in this population is said to be ``normally distributed´´? | 749 | ||
3. What does a small coefficient of variation for the sample in the blood pressure study imply? | 750 | ||
4. Quick review: What percentage of the men in this study had a blood pressure in the following ranges? | 750 | ||
case25-3 | 751 | ||
1. Why does it make sense to use a screening test with a high sensitivity, even at the cost of specificity, for this patient? | 751 | ||
2. If this patient tests positive, is it reasonable to tell him that you are 95% confident that he is infected with human | 751 | ||
3. What if the test comes back negative? Can you tell this patient that you are 75% confident that he does not have human | 751 | ||
4. Now let's assume that 90-year-old grandma and our young drug-abusing model citizen in this vignette both test positive for | 751 | ||
Case25-4 | 752 | ||
1. Given the data presented in the 22 table in Table 25-7, what is the sensitivity of this new test? | 752 | ||
2. What is the specificity of this new test? | 752 | ||
3. What information can be obtained from calculating the positive likelihood ratio? | 752 | ||
4. How is the positive likelihood ratio used to calculate the positive predictive value? | 753 | ||
5. If the positive likelihood ratio is not known, what is another way to calculate the positive predictive value? | 753 | ||
6. How is the negative predictive value calculated? | 753 | ||
7. Using the same preceding example for the calculation of the positive predictive value, calculate the negative predictive v | 753 | ||
Case25-5 | 754 | ||
1. What type of study design is this? | 754 | ||
2. What is the difference between a prospective cohort study and a retrospective cohort study? | 754 | ||
3. What is the major limitation of cohort studies? | 754 | ||
4. On the basis of data presented in Table 25-8, what is the relative risk for cancer in the exposed group? | 755 | ||
5. What is meant by attributable risk and attributable risk percent? Calculate both for the preceding example. | 755 | ||
6. What experimental design overcomes the shortcomings of the cohort study? | 756 | ||
Chapter 26: Clinical Anatomy | 757 | ||
Case26-1 | 757 | ||
1. What is the differential diagnosis for his foot and lower extremity pain? | 758 | ||
Case26-1 continued: | 758 | ||
2. What is now the most likely diagnosis? | 758 | ||
3. Which historical features in this patient increase the likelihood of a peripheral vascular disease diagnosis? | 758 | ||
4. Why does his nocturnal right foot pain resolve when he hangs the affected foot over the bedside? | 758 | ||
5. Describe the path of arterial blood from the heart to the femoral sheath. | 758 | ||
6. Outline the borders of the femoral triangle. | 758 | ||
7. Describe the path of arterial blood from the femoral sheath to the feet. | 759 | ||
8. At which sites is arterial plaque formation most likely? | 759 | ||
9. In Table26-1, cover the two columns on the right and attempt to list the drug class and mechanism of action for each of | 760 | ||
Case26-2, Part A | 761 | ||
1. What structure has Oscar injured, and how has it led to his upper extremity position? | 762 | ||
2. If Oscar had forced his upper extremity above his head by grabbing the handlebars of the motorcycle to prevent his fall, h | 762 | ||
Case26-2, Part A continued: | 762 | ||
3. What structure has Oscar injured this time and how has it led to his upper extremity position? | 763 | ||
Case26-2, Part B | 763 | ||
4. What structure has been injured and how has this happened? | 763 | ||
5. Outline the contents of the carpal tunnel. | 763 | ||
6. Name the muscles of the thenar and hypothenar eminences and describe their function. | 763 | ||
7. Describe the pattern of sensory innervation of the hand. | 763 | ||
Case26-2, Part B continued: | 764 | ||
8. What fracture has George suffered? | 764 | ||
Case26-2, Part C | 764 | ||
9. What are the three most common sites of humerus fracture, and which nerve and artery are at risk at each of these sites? | 764 | ||
10. On reviewing Jake's past medical history, you note that his baseball career was marred by a partially torn rotator cuff. | 766 | ||
Case26-3, Part A | 767 | ||
1. What is the most likely diagnosis? | 767 | ||
2. What is the utility of the ductus arteriosus? | 767 | ||
3. What causes the ductus arteriosus to close after birth? | 767 | ||
Case26-3, Part B | 769 | ||
4. What is the most likely diagnosis? | 769 | ||
5. Is atrial septal defect the most common congenital heart defect? | 769 | ||
6. What are the three most common types of atrial septal defect? | 769 | ||
7. How might atrial septal defect lead to right-sided heart failure? | 769 | ||
8. What is the dreaded late complication of atrial septal defect? | 769 | ||
Case26-3, Part C | 770 | ||
9. What are the five cardiogenic causes of cyanosis in a newborn? | 770 | ||
Case26-3, Part D | 770 | ||
10. What is the most likely diagnosis? | 770 | ||
11. How does tetralogy of Fallot cause cyanosis? | 771 | ||
12. What is the cause of tetralogy of Fallot? | 771 | ||
Case26-4, Part A | 772 | ||
1. What is the differential diagnosis for John's symptoms? | 772 | ||
Case26-4, Part A continued: | 772 | ||
2. What is the most likely diagnosis and what is the next step to confirm this suspicion? | 772 | ||
3. At what spinal level should a lumbar puncture be performed? Why? | 772 | ||
4. Through what major structures and spaces, from superficial to deep, should the needle pass in a lumbar puncture? | 772 | ||
5. Describe the three layers of the meninges. | 773 | ||
6. What cerebrospinal fluid findings would you expect to find with different causes of meningitis? | 774 | ||
7. What are the most common causes of meningitis by age group? | 774 | ||
Case26-4, Part B | 774 | ||
8. What disorder of neurologic development can be characterized by these findings? | 775 | ||
9. What are the other significant disorders related to a failure of posterior neural tube closure? | 775 | ||
Case26-4, Part C | 775 | ||
10. What is the most likely diagnosis? | 775 | ||
11. Describe intervertebral disk anatomy and how herniation usually occurs. | 775 | ||
12. Describe the pattern of nerve compression seen in intervertebral disk herniations. | 775 | ||
Case26-5 | 777 | ||
1. Describe the characteristics of the most likely diagnosis. | 778 | ||
2. What differentiates a direct from an indirect inguinal hernia? | 778 | ||
3. Describe the structure of the inguinal canal. | 778 | ||
4. Discuss the major contents of the spermatic cord. | 779 | ||
5. Which lymph nodes are the most likely site of first metastasis in testicular cancer? Why is this the case? | 779 | ||
6. After a vasectomy, by what means does a male produce an ejaculate that does not include sperm? Include a summary of the pa | 780 | ||
7. Describe the neurologic basis for erection, emission, and ejaculation. | 781 | ||
8. Name the most common drugs used for treatment of erectile dysfunction and outline their mechanism of action. | 781 | ||
Case26-6 | 782 | ||
1. What is the differential diagnosis for Carlos's symptoms? | 782 | ||
Case26-6 continued: | 782 | ||
2. Which of the possibilities is now the most likely diagnosis? | 782 | ||
3. Outline varicocele pathophysiology. Be sure to explain why varicocele is more likely to occur on the left than on the righ | 782 | ||
4. Describe the difference between hydrocele and hematocele. | 783 | ||
Case26-6 continued: | 783 | ||
5. What are esophageal varices? | 784 | ||
6. How do the esophageal veins connect the portal and systemic venous systems? | 784 | ||
7. Outline the flow of blood to the superior vena cava through the veins of the azygous system. | 784 | ||
Case26-7, Part A | 785 | ||
1. List the structures that Nikolai has injured. | 785 | ||
2. How does the posterior cruciate ligament differ from the anterior cruciate ligament? | 786 | ||
3. Explain why Nikolai's medial collateral ligament and anterior cruciate ligament tears led to the tear in his lateral menis | 786 | ||
Case26-7, Part A continued: | 786 | ||
4. Nikolai's clinical picture suggests injury to what structure? | 786 | ||
5. How does injury to the common fibular nerve result in footdrop, as seen in Nikolai? | 786 | ||
6. List the muscles of the posterior compartment of the leg and describe their innervation. | 788 | ||
Case26-7, Part A continued: | 788 | ||
7. What dreaded vascular surgery complication has Nikolai suffered? | 789 | ||
8. What divides the compartments of the leg? | 789 | ||
9. Describe the major pathophysiologic characteristics of compartment syndrome. | 789 | ||
Case26-7, Part B | 789 | ||
10. What structure has been injured and how has this led to her awkward gait? | 790 | ||
Case26-8, Part A | 791 | ||
1. What is the differential diagnosis for Maureen's hoarseness? | 791 | ||
2. Given the surgical history, which of these diagnoses is most likely and why? | 791 | ||
3. How does injury to the recurrent laryngeal nerve result in hoarseness? | 791 | ||
4. Describe the path of the recurrent laryngeal nerve, noting any asymmetries. | 792 | ||
5. Describe the innervation of the lone intrinsic laryngeal muscle not innervated by the recurrent laryngeal nerve: the crico | 792 | ||
Case26-8, Part B | 792 | ||
6. To save this man's life, which structure must you incise? Why? | 793 | ||
7. Describe the surface anatomy of the neck that allows one to find the cricothyroid membrane. | 793 | ||
Case26-8, Part C | 793 | ||
8. With what defect(s) has this child been born? | 793 | ||
9. Describe the embryologic basis for cleft lip. | 793 | ||
10. Describe the embryologic basis for cleft palate. | 793 | ||
Other important concepts in embryology of the face and neck | 793 | ||
11. Discuss the difference between pharyngeal (branchial) pouches, arches, and clefts. | 793 | ||
12. In Table 26-5, cover the right column and name the derivatives of each structure listed in the left column. | 795 | ||
13. From where do the parts of the thyroid gland, other than the parafollicular C cells, originate? | 796 | ||
Case26-9 | 796 | ||
1. What is the differential diagnosis for Janice's right upper quadrant pain? | 796 | ||
Case26-9 continued: | 797 | ||
2. What is the most likely diagnosis? | 797 | ||
3. Name the two most common organisms implicated in pelvic inflammatory disease. | 797 | ||
4. How can pelvic inflammatory disease lead to right upper quadrant pain? | 797 | ||
5. Describe how the uterus and ovaries are supported. | 797 | ||
6. Can Fitz-Hugh-Curtis syndrome be seen in males? | 797 | ||
7. Outline the common drugs used in antimicrobial pharmacotherapy for pelvic inflammatory disease. | 797 | ||
8. In Table 26-6, cover the column on the right and name the abdominal organs in each location. | 798 | ||
Case26-10, Part A | 799 | ||
1. What is the differential diagnosis for David's chest pain? | 800 | ||
2. A myocardial infarction in what distribution would be most concerning for damage to the sinoatrial and atrioventricular no | 800 | ||
3. Which coronary arteries supply the left ventricle? | 800 | ||
4. If David's chest pain were caused by pleuritis (also known as pleurisy), from which pleural layer would he be sensing pain | 801 | ||
Case26-10, Part A continued: | 801 | ||
5. What is the most likely diagnosis? | 801 | ||
6. If one were to pass a needle from outside the pericardium to the lumen of the left ventricle, through which layers would i | 801 | ||
7. Enlargement of which chamber of the heart is most likely to cause dysphagia? | 801 | ||
8. Enlargement of which chamber of the heart is most likely to cause a parasternal lift? | 801 | ||
Case26-10, Part B | 801 | ||
9. If the candy passed into the bronchial tree, on which side would it most likely be found? | 802 | ||
10. Describe the other major asymmetry of the bronchial tree. | 803 | ||
11. List the four stages in lung development and note whether each is compatible with life. | 803 | ||
Chapter 27: Pathology | 805 | ||
1. A 67-year-old white man presented to the emergency department (ED) with worsening dyspnea and cough at night. Physical exa | 805 | ||
2. A 62-year-old obese woman with a history of long-standing gastroesophageal reflux disease (GERD) presented to her primary | 805 | ||
3. A 45-year-old homeless man, positive for human immunodeficiency virus (HIV), presented to the ED with reported chronic cou | 806 | ||
4. A 35-year-old white woman presents to the ED with acute left lower quadrant abdominal pain that has been sharp and constan | 806 | ||
5. A 60-year-old white man with a history of hyperlipidemia and diabetes mellitus type 2 presents to the ED with worsening ch | 806 | ||
6. A 55-year-old white man presented to the ED after suffering severe injuries in a motor vehicle accident. His blood alcohol | 806 | ||
7. A 46-year-old white man presents to his primary care physician with a 1-year history of fatigue, weakness, and arthralgias | 807 | ||
8. A 74-year-old woman presents to her primary care physician complaining of constipation and hard stools for the past severa | 807 | ||
9. A 60-year-old woman presents to her primary care physician complaining of feeling bloated and full for the past 2months no | 808 | ||
10. A 38-year-old woman is referred by her primary care physician to a surgeon for treatment for a newly palpated, asymptomat | 808 | ||
11. A 77-year-old white man presents to his primary care physician for his annual physical and was found to have a lesion on | 808 | ||
12. A 71-year-old man presents to his primary care physician for the first time in over 10years with complaints of fatigue an | 808 | ||
13. A 95-year-old man is brought to the ED for worsening SOB, fever, and productive cough. He is stabilized in the ED and adm | 809 | ||
14. A 21-year-old woman presents to her gynecologist for her yearly Papanicolaou (Pap) smear. She has been sexually active wi | 809 | ||
15. A 71-year-old man is brought to the ED with an acute exacerbation of congestive heart failure. He has had long-standing l | 809 | ||
16. A 48-year-old woman is referred by her gynecologist to a surgeon for a newly palpated lump in her right breast that was n | 809 | ||
17. A 15-year-old boy's father dies at the age of 50. An autopsy is performed, and the gross colon specimen is shown in Figur | 809 | ||
18. A 62-year-old man develops severe chest pain that radiates down his left arm while eating dinner at home. He has a histor | 810 | ||
19. A 63-year-old native Hawaiian woman presents to her primary care physician with worsening dull, aching back pain and fati | 810 | ||
20. A 69-year-old white man presents to his primary care physician with a 4-week history of worsening cough productive of blo | 810 | ||
21. A 26-year-old white man has a 2-week history of fevers that come and go, night sweats, and cervical and supraclavicular l | 811 | ||
22. A 66-year-old man with a history of diabetes mellitus and many hospital admissions for nausea and vomiting was killed in | 811 | ||
23. A 55-year-old African-American man with a history of GERD presents to his primary care physician with a 10-lb weight loss | 811 | ||
24. A 72-year-old African-American man presents to his primary care physician with a 7-week history of worsening cough produc | 812 | ||
25. A 55-year-old man presents to his primary care physician with a 3-week history of fever that comes and goes, a weight los | 812 | ||
26. A 32-year-old man presents to his primary care physician complaining of a lump in his testicle that has been present for | 812 | ||
27. A 65-year-old African-American man presents to his primary care physician with a 4-month history of fatigue and dyspnea o | 813 | ||
28. An 85-year-old man presents to his primary care physician with a 2-week history of what the patient describes as hives on | 813 | ||
29. A 61-year-old white woman is brought to the ED in critical condition following a motor vehicle accident. On physical exam | 813 | ||
30. A 67-year-old white man is brought to the ED from his primary care physician's office with decreased urine output, hemopt | 814 | ||
31. A 68-year-old man presents to his primary care physician with worsening dysphagia and odynophagia. The patient states tha | 814 | ||
32. A 32-year-old woman undergoes a kidney transplantation, and 2weeks after surgery, she develops stomach pain, diarrhea, we | 814 | ||
33. An 83-year-old white man is brought to his primary care physician by his daughter for a newly discovered skin lesion. The | 815 | ||
34. A 22-year-old woman presents to her primary care physician with complaints of fatigue and dyspnea on exertion for the pas | 815 | ||
35. A 45-year-old premenopausal obese African-American woman presents to her gynecologist with complaints of menorrhagia and | 815 | ||
36. A 59-year-old white man with a history of hypertension and hyperlipidemia presents to the ED with severe chest pain that | 815 | ||
37. A 14-year-old African-American boy has a history of splenomegaly and undergoes a splenectomy. A section of his spleen is | 816 | ||
38. An 18-year-old woman presents to her primary care physician with complaints of diarrhea, weight loss (5lb), and abdominal | 816 | ||
39. A 30-year-old woman from the northeastern part of the United States presents to her primary care physician with crampy ri | 816 | ||
40. A 45-year-old homeless man is brought to the ED with vomiting and fever. On physical examination, he is disheveled and ha | 816 | ||
41. A 35-year-old Hawaiian man presents to his primary care physician for his yearly physical. The only complaint that he has | 817 | ||
42. A 70-year-old retired man, who worked in a ceramics manufacturing facility, presents to his primary care physician with w | 817 | ||
43. A 51-year-old woman presents to her primary care physician with weight gain of 10lb in the last month, along with fatigue | 817 | ||
44. A 4-year-old child presents to the ED with respiratory distress. He had functioned normally at birth until 6months of age | 818 | ||
45. A 44-year-old woman presents to her physician with arthralgias, fatigue, malaise, and fevers. She also notes that within | 818 | ||
46. A 40-year-old woman has chronic back pain secondary to an automobile accident 5years earlier that has been worsening for | 819 | ||
47. A 72-year-old man presented to his primary care physician complaining of a weight loss of 10lb in 1month and a feeling of | 819 | ||
48. A 30-year-old woman presents to her primary care physician with weight loss, palpitations, and sweating. On physical exam | 819 | ||
49. A 54-year-old woman is brought to the ED by ambulance with acute SOB. The patient states (through labored breathing) that | 820 | ||
50. A 64-year-old white man presents to his primary care physician with complaints of four episodes of hematuria over the pas | 820 | ||
Chapter 28: ECG | 821 | ||
1. An ECG recorded in a 30-year-old healthy woman is shown in Figure 28-1. How would you interpret this ECG? | 821 | ||
2. An ECG recorded in a febrile septic patient is shown in Figure 28-2. How would you interpret this ECG? | 821 | ||
3. An ECG recorded in a healthy middle-aged man after he became dizzy and diaphoretic while having blood drawn is shown in Fi | 822 | ||
4. The patient whose ECG is shown in Figure 28-4 will almost certainly remain asymptomatic throughout life but is at marg | 822 | ||
5. The ECG shown in Figure28-5 comes from a 52-year-old man with chronic obstructive pulmonary disease (COPD) follow | 823 | ||
6. An ECG recorded in a patient with sudden onset of palpitations and rapid heart rate is shown in Figure 28-6. How would | 823 | ||
7. An ECG in a 38-year-old woman experiencing severe nausea is shown in Figure 28-7. How would you interpret this ECG? | 824 | ||
8. An ECG recorded in an asymptomatic middle-aged man is shown in Figure 28-8. How would you interpret this ECG? Does h | 824 | ||
9. An ECG recorded in an elderly woman is shown in Figure 28-9. How would you interpret this ECG? Does she require a pace | 825 | ||
10. An ECG recorded in a 74-year-old man with recurrent syncope is shown in Figure 28-10. How would you interpret this ECG | 825 | ||
11. Figure28-11 shows an ECG recorded in a 55-year-old man with a history of a massive myocardial infarction 5 years | 826 | ||
12. An ECG from a middle-aged man started on procainamide for atrial fibrillation is shown in Figure 28-12. How would yo | 826 | ||
13. Figure28-13 shows an ECG recorded in a 32-year-old otherwise healthy female smoker who takes birth control pills | 826 | ||
14. Figure28-14 shows an ECG recorded in a 52-year-old diabetic smoker who is experiencing sudden onset of chest pain | 827 | ||
15. An ECG recorded in a 75-year-old man with a history of coronary artery disease who is experiencing severe substernal ches | 827 | ||
16. Figure28-16 shows an ECG from a 42-year-old obese man who is experiencing severe chest pain. How would you interp | 827 | ||
Index | 829 | ||
Color Plates | 865 |